<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">787633</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2021.787633</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Propolis in Oral Healthcare: Antibacterial Activity of a Composite Resin Enriched With Brazilian Red Propolis</article-title>
<alt-title alt-title-type="left-running-head">Oliveira et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Antibacterial BRP Enriched Composite Resin</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Oliveira</surname>
<given-names>Jos&#xe9; Marcos dos Santos</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1380043/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cavalcanti</surname>
<given-names>Th&#xe9;o Fortes Silveira</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leite</surname>
<given-names>Ingrid Ferreira</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1529746/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>dos Santos</surname>
<given-names>D&#xe1;vida Maria Ribeiro Cardoso</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Porto</surname>
<given-names>Isabel Cristina Celerino de Moraes</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/71136/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Aquino</surname>
<given-names>Fernanda Lima Torres</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sonsin</surname>
<given-names>Artur Falqueto</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lins</surname>
<given-names>Renata Matos Lamenha</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1543674/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vitti</surname>
<given-names>Rafael Pino</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Freitas</surname>
<given-names>Johnnatan Duarte</given-names>
</name>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barreto</surname>
<given-names>Emiliano de Oliveira</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/778435/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Souza</surname>
<given-names>Samuel Teixeira</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1459089/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamiya</surname>
<given-names>Regianne Umeko</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>do Nascimento</surname>
<given-names>Ticiano Gomes</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tonholo</surname>
<given-names>Josealdo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/85626/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Postgraduate Program of Chemistry and Biotechnology, Institute of Chemistry and Biotechnology, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Postgraduate Program in Health Research, Cesmac University Center, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Postgraduate Program in Materials, Center of Technology, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Faculty of Dentistry, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>Postgraduate Program Multicenter of Biochemistry and Molecular Biology, Institute of Pharmaceutical Sciences, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff6">
<label>
<sup>6</sup>
</label>Postgraduate Program in Pharmaceutical Sciences, Institute of Pharmaceutical Sciences, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff7">
<label>
<sup>7</sup>
</label>Postgraduate Program in Health Sciences, Institute of Biological and Health Sciences, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff8">
<label>
<sup>8</sup>
</label>Postgraduate Program in Physics, Institute of Physics, Federal University of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff9">
<label>
<sup>9</sup>
</label>Faculty of Dentistry, Herm&#x00ED;nio Ometto Foundation, <addr-line>Araras</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff10">
<label>
<sup>10</sup>
</label>Department of Chemistry, Federal Institute of Alagoas, <addr-line>Macei&#xf3;</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/754413/overview">Jose Mauricio Sforcin</ext-link>, S&#xe3;o Paulo State University, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/577948/overview">Luis A. Salazar</ext-link>, University of La Frontera, Chile</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/949152/overview">Ary Fernandes Junior</ext-link>, S&#xe3;o Paulo State University, Brazil</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jos&#xe9; Marcos dos Santos Oliveira, <email>jose_marcos_cbjr@hotmail.com</email>, <email>oliveira.jms91@gmail.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>787633</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Oliveira, Cavalcanti, Leite, dos Santos, Porto, de Aquino, Sonsin, Lins, Vitti, de Freitas, Barreto, de Souza, Kamiya, do Nascimento and Tonholo.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Oliveira, Cavalcanti, Leite, dos Santos, Porto, de Aquino, Sonsin, Lins, Vitti, de Freitas, Barreto, de Souza, Kamiya, do Nascimento and Tonholo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>The aim of this study was to obtain a Brazilian red propolis (BRP) enriched composite resin and to perform the characterization of its antibacterial activity, mechanical, and physical-chemical properties. Brazilian red propolis ethyl acetate extract (EABRP) was characterized by LC-ESI-Orbitrap-FTMS, UPLC-DAD, antibacterial activity, total flavonoids content, and radical scavenging capacity. BRP was incorporated to a commercial composite resin (RC) to obtain BRP enriched composite at 0.1, 0.15 and 0.25% (RP10, RP15 and RP25, respectively). The antibacterial activity RPs was evaluated against <italic>Streptococcus mutans</italic> by contact direct test and expressed by antibacterial ratio. The RPs were characterized as its cytotoxicity against 3T3 fibroblasts, flexural strength (FS), Knoop microhardness (KHN), post-cure depth (CD), degree of conversion (DC%), water sorption (Wsp), water solubility (Wsl), average roughness (Ra), and thermal analysis. Were identified 50 chemical compounds from BRP extract by LC-ESI-Orbitrap-FTMS. EABRP was bacteriostatic and bactericide at 125 and 500&#xa0;&#x3bc;g/ml, respectively. The RP25 exhibited antibacterial ratio of 90.76% after 1&#xa0;h of direct contact with <italic>S. mutans</italic> (<italic>p</italic>&#x20;&#x3c; 0.0001) while RC no showed significative antibacterial activity (<italic>p</italic>&#x20;&#x3d; 0.1865), both compared with cell control group. RPs and RC no showed cytotoxicity. RPs exhibited CD from 2.74 to 4.48&#xa0;mm, DC% from 80.70 to 83.96%, Wsp from 17.15 to 21.67&#xa0;&#x3bc;g/mm<sup>3</sup>, Wsl from 3.66 to 4.20&#xa0;&#x3bc;g/mm<sup>3</sup>, Ra from 14.48 to 20.76&#xa0;nm. RPs showed thermal resistance between 448&#x2013;455&#xb0;C. The results support that propolis can be used on development of modified composite resins that show antibacterial activity and that have compatible mechanical and physical-chemical properties to the indicate for composite resins.</p>
</abstract>
<kwd-group>
<kwd>propolis</kwd>
<kwd>antibacterial activity</kwd>
<kwd>
<italic>Streptococcus mutans</italic>
</kwd>
<kwd>dental materials</kwd>
<kwd>mechanical properties</kwd>
<kwd>fibroblasts</kwd>
<kwd>composite resin</kwd>
<kwd>direct contact test</kwd>
</kwd-group>
<contract-num rid="cn001">870220/2000-4 140765/2016-6</contract-num>
<contract-sponsor id="cn001">Conselho Nacional de Desenvolvimento Cient&#xed;fico e Tecnol&#xf3;gico<named-content content-type="fundref-id">10.13039/501100003593</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Propolis is a natural, nontoxic, raw material collected by <italic>Apis mellifera</italic> bee from plants sources as exudates, tree barks and leaf buds from various plant sources (<xref ref-type="bibr" rid="B40">Koo et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B16">da silva Barboza et&#x20;al., 2021</xref>). Diverse types of propolis are known around the world and each type differs in its chemical composition, this variation occurs in function of its botanic origin, a local main plant source used by bee for propolis obtention (<xref ref-type="bibr" rid="B76">Teixeira et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B18">Daugsch et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B67">Ristivojevi&#x107; et&#x20;al., 2015</xref>). The botanical origin of red propolis collected in northeastern Brazil is the <italic>Dalbergia ecastaphyllum</italic> (L.) Taub<italic>.</italic> (Fabaceae), that is known by has a red resinous exudate from holes in its branches (<xref ref-type="bibr" rid="B18">Daugsch et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B62">Piccinelli et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B30">Freires et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B17">Dantas Silva et&#x20;al., 2017</xref>). The Brazilian red propolis (BRP) can be found in beehives located on the coast of northeastern between states of Bahia, Sergipe, Alagoas, Pernambuco, Para&#xed;ba, Rio Grande do Norte, Cear&#xe1; and Maranh&#xe3;o. The Red propolis from Alagoas state obtained the Geographic Indication (GI) by the Brazilian National Institute of Industrial Property (INPI) (<xref ref-type="bibr" rid="B30">Freires et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B17">Dantas Silva et&#x20;al., 2017</xref>). The chemical composition of BRP are rich mainly in isoflavonoids, flavonoids, benzophenones, phenolic acids and terpenes, and has more than 200 compounds as constituents and/or markers (<xref ref-type="bibr" rid="B21">de Mendon&#xe7;a et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B30">Freires et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B24">do Nascimento et&#x20;al., 2019</xref>). Some pharmacologic activities are attribute to BRP as antibacterial (<xref ref-type="bibr" rid="B72">Sforcin and Bankova, 2011</xref>; <xref ref-type="bibr" rid="B11">Bueno-Silva et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B17">Dantas Silva et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B16">da silva Barboza et&#x20;al., 2021</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B44">Lima Cavendish et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B29">Franchin et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B15">Corr&#xea;a et&#x20;al., 2017</xref>) and wound healing (<xref ref-type="bibr" rid="B38">Jacob et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B15">Corr&#xea;a et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B58">Oryan et&#x20;al., 2018</xref>).</p>
<p>Propolis has been used in dentistry and oral healthcare due to its pharmacological properties and absence of toxicity ensured even by its use in traditional medicine (<xref ref-type="bibr" rid="B72">Sforcin and Bankova, 2011</xref>; <xref ref-type="bibr" rid="B16">da silva Barboza et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B85">Zulhendri et&#x20;al., 2021</xref>). Among the possibilities of propolis use in dentistry and oral healthcare are: in inhibition of adhesion and biofilm formation of <italic>Candida species</italic> in dentistry materials (<xref ref-type="bibr" rid="B9">Bezerra et&#x20;al., 2020</xref>), on development of endodontic irrigants (<xref ref-type="bibr" rid="B59">Parolia et&#x20;al., 2021</xref>), on development of varnishes (<xref ref-type="bibr" rid="B20">De Luca et&#x20;al., 2014</xref>), on development of total-etching adhesive system (<xref ref-type="bibr" rid="B65">Porto et&#x20;al., 2021</xref>), as cavity cleaning agent (<xref ref-type="bibr" rid="B13">Celerino de Moraes Porto et&#x20;al., 2018</xref>), on mouthwash development (<xref ref-type="bibr" rid="B70">Santiago et&#x20;al., 2018</xref>), on gel formulation development (<xref ref-type="bibr" rid="B32">Gonz&#xe1;lez-Serrano et&#x20;al., 2021</xref>) and on oromuco-adhesive films development (<xref ref-type="bibr" rid="B5">Arafa et&#x20;al., 2018</xref>).</p>
<p>Composite resins are dental restorative materials that contain an organic matrix, inorganic fillers, bonding agents and a photoinitiator system (<xref ref-type="bibr" rid="B27">Ferracane, 2011</xref>). The organic matrix of composite resin content mainly dimethacrylate monomers as bisphenylglycidyl BisGMA, triethylene glycol dimethacrylate (TEGDMA), ethoxylated bisphenol-A dimethacrylate (BisEMA) and Urethane dimethacrylate (UDMA) (<xref ref-type="bibr" rid="B28">Floyd and Dickens, 2006</xref>; <xref ref-type="bibr" rid="B33">Go&#x146;&#xe7;alves et&#x20;al., 2009</xref>). The proportion of each dimethacrylate monomers used influences on formation of cross-links in the 3D structure of the polymer and, consequently, in the mechanical properties of composite (<xref ref-type="bibr" rid="B1">Achilias et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B77">Vouvoudi et&#x20;al., 2015</xref>). The viscosity of these composites is established by filler content, and this component is a main responsible for the mechanical strength of composites (<xref ref-type="bibr" rid="B46">Liu et&#x20;al., 2015</xref>). The main filler components used in composite resin are titanium dioxide (TiO<sub>2</sub>), ceramic, and zirconia (ZrO<sub>2</sub>) ceramic in form of micro/nanoparticles (<xref ref-type="bibr" rid="B48">Makvandi et&#x20;al., 2018</xref>). Currently, the development of modified composite resins that have antibacterial activity and compatible mechanic and physical-chemical properties with use has been sought (<xref ref-type="bibr" rid="B49">Makvandi et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B78">Wang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B43">Liang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B22">Dias et&#x20;al., 2019</xref>).</p>
<p>In this context, the purpose of this study was to modify a commercial composite resin with Brazilian red propolis to obtaining a BRP enriched composite resin that shows antibacterial activity and compatible mechanic and physical-chemical properties with intend use. The null hypothesis tested in this study is that the BRP addiction into a commercial composite resin no provide antibacterial activity, nor compatible mechanic and physical-chemical properties with intend&#x20;use.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Collection of Brazilian Red Propolis and Extracts Obtainment</title>
<p>Brazilian red propolis (BRP) raw material was collected in the city of Marechal Deodoro, Alagoas, Brazil in July 2013 (geographic coordinates south latitude: 9&#xb0; 42.258&#x2032;, west latitude: 35&#xb0; 54.391&#x2032; and height of 35.5&#xa0;m above sea level). The access and transportation of Brazilian red propolis was previously authorized by regulatory agencies for control of Brazilian Genetic Heritage and Biodiversity Conservation with protocol number of acceptance 010124/2012-8. The Brazilian red propolis ethanol extract (EBRP) was obtained by extraction of BRP (250&#xa0;g) through maceration method where raw propolis was manually ground and placed in glass flask with 600&#xa0;ml of 80% ethanol (v/v) under agitation for 48&#xa0;h. After this time, the macerate (liquid portion) was removed using a pipette, placed in another glass flask and the resinous mass deposited at the deep of firth glass flask was submitted to new extraction with more 600&#xa0;ml of 80% ethanol at the same conditions. After the end of 2 cycles of extraction, the total macerate was joined and concentrated in a rotary evaporator (Fisatom, Brazil) in a vacuum at 40&#xb0;C. The EBRP was then placed in a glass container and left for approximately 3&#xa0;days for the residual solvent to evaporate. As a result, a solid mass (162&#xa0;g) with viscous appearance was obtained.</p>
<p>A liquid-liquid extraction of EBRP was carried with hexane and ethyl acetate to eliminate grease and waxes and to concentrate flavonoids, respectively. EBRP (20&#xa0;g) was solubilized with 60&#xa0;ml of 70% ethanol (v/v) and successively fractioned with hexane (100&#xa0;ml, twice) and right after with ethyl acetate (100&#xa0;ml, twice) giving rise to the Brazilian red propolis hexane extract (HBRP) and the Brazilian red propolis ethyl acetate extract (EABRP), respectively. The EABRP was concentrated in a rotary evaporator to obtain a solid mass (4.0&#xa0;g) and stored in a freezer at &#x2212;20&#xb0;C until further analysis.</p>
</sec>
<sec id="s2-2">
<title>Chemical Characterization and Antibacterial Assay of Brazilian Red Propolis Extracts</title>
<sec id="s2-2-1">
<title>Analysis of Red Propolis by LC-ESI-Orbitrap-FTMS</title>
<p>The LC-MS analysis was performed using a LC-Orbitrap-FTMS system consisted of an Accela 600 HPLC system combined with an Exactive (Orbitrap) mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) including on-line DAD (200&#x2013;600&#xa0;nm) and UV at 280&#xa0;nm analysis. The chromatographic separation of the compounds from red propolis was performed using an ACE<sup>&#xae;</sup> C18 columns (100 &#xd7;&#x20;4.6&#xa0;mm; 3&#xa0;&#xb5;m) from (Hichrom, Reading United&#x20;Kingdom) and a mobile phase (0.1% of formic acid in H2O: 0.1% of formic acid in Acetonitrile; A:B) in flow rate of 300&#xa0;&#x3bc;l/min. The gradient elution was programmed as follows: 0&#x2013;6&#xa0;min linear gradient 30&#x2013;45% of B, 6&#x2013;14&#xa0;min linear gradient 45&#x2013;75% of B, 14&#x2013;20&#xa0;min linear gradient 75&#x2013;100% of B, 20&#x2013;51&#xa0;min at 100% of B for elution of the guttiferones and cleaning of the column, 51&#x2013;54&#xa0;min decreasing in B to 45%, 54&#x2013;55 linear gradient 30% of B, 55&#x2013;60&#xa0;min isocratic condition with 30% of B to re-equilibration of the column for next run. The injection volume was 10&#xa0;&#xb5;l. The MS detection range was from 100 to 1200&#xa0;m/z set at 30,000 resolutions and the scanning was performed under ESI negative polarity mode with capillary temperature was 250&#xb0;C.</p>
</sec>
<sec id="s2-2-2">
<title>Analysis of Red Propolis by UPLC-PDA</title>
<p>An ultra-performance liquid chromatography coupled with a photodiode array (UPLC-PDA) analysis was performed using an UPLC-PDA system from Shimadzu (Tokyo, Japan). The UPLC-PDA equipment consisted of the modules: degasser (model DGU-20A3R), two high-pressure pumps (model LC-20ADXR), auto-injector (model SIL-20AXR), oven chromatographic column (Prominence<sup>&#xae;</sup> CTO-20A), photodiode array detector (model SPD-M20A), a controller (model CBM-20A), and Shimadzu Labsolution software. The chromatographic separation of flavonoids from red propolis was performed using a Kinetex<sup>&#xae;</sup> C18- column (150&#xa0;mm &#xd7; 4.6&#xa0;mm; 5&#xa0;&#xb5;m) and a mobile phase that consisted of solvent A (Milli-Q water) and solvent B (acetonitrile) pumped at flow rate of 0.3&#xa0;ml/min. The initial elution gradient consisted of 70% water (A) and 30% acetonitrile (B) (v/v). The column was eluted by varying the percentage of (B) as follows: 0&#x2013;2&#xa0;min 30% B, 2&#x2013;5&#xa0;min 36% B, 5&#x2013;8&#xa0;min 46% B, 8&#x2013;11&#xa0;min 52% B, 11&#x2013;14&#xa0;min 52% B, 14&#x2013;17&#xa0;min 57% B, 17&#x2013;20&#xa0;min 62% B, 20&#x2013;24&#xa0;min 62% B, 24&#x2013;28&#xa0;min 68% B, 28&#x2013;32&#xa0;min 72% B, 32&#x2013;36&#xa0;min 90% B, 36&#x2013;42&#xa0;min 97% B, 42&#x2013;50&#xa0;min 100% B, 50&#x2013;55&#xa0;min 100% B, 55&#x2013;57&#xa0;min acetonitrile was reduced to 30% and this condition was maintained up to 60&#xa0;min. Volumetric working solutions of analytical standards of the daidzein, liquiritigenin, pinobanksin, isoliquiritigenin, formononetin, pinocembrin, and biochanin A from Sigma-Aldrich (St. Louis, MO, United&#x20;States) was prepared at 200&#xa0;&#x3bc;g/ml (ethanolic solutions). After that, the working solutions were diluted to obtain a calibration curve at the concentrations: 7.50, 5.00, 2.50, 1.00, 0.50 and 0.15&#xa0;&#x3bc;g/ml (<italic>n</italic>&#x20;&#x3d; 3). This calibration curve was used for the quantification of the listed flavonoids in the EABRP dried extract. The EABRP lyophilized extract (EABRP dried extract) were solubilized in ethanol (HPLC grade) to obtain stock solution at 10&#xa0;mg/ml. Then, 250&#xa0;&#xb5;l of EABRP stock solution was pipetted to 5&#xa0;ml volumetric flasks (<italic>n</italic>&#x20;&#x3d; 3) to obtain work solutions at 500&#xa0;&#x3bc;g/ml. The injection volume of each sample was 2.0&#xa0;&#xb5;l. The UPLC-PDA method was previously validated to the quantification of markers from Brazilian red propolis (<xref ref-type="bibr" rid="B23">do Nascimento et&#x20;al., 2016</xref>). The analysis was carried out at 280&#xa0;nm.</p>
</sec>
<sec id="s2-2-3">
<title>Antibacterial Activity of Brazilian Red Propolis Extracts</title>
<p>The EBRP and EABRP were tested against <italic>Streptococcus mutans</italic> CCT 3440 from Tropical Cultures Collection (CCT). The strain was provided by Andr&#xe9; Tosello Foundation (Campinas, S&#xe3;o Paulo, Brazil). The stock solutions of EBRP and EABRP were prepared at 30&#xa0;mg/ml in acetone and diluted, first to 10&#xa0;mg/ml in 1.0% dimethyl sulfoxide (DMSO) and after to 2500&#xa0;&#x3bc;g/ml (1.0% DMSO). This dilution process was performed to minimize the acetone&#x2019;s antibacterial action in the assay. The final solutions of EBRP and EABRP (2500&#xa0;&#x3bc;g/ml in 1.0% DMSO) was made in the same day of the broth microdilution assay. The <italic>S. mutans</italic> CCT 3440 strain was activated in BHA (brain heart infusion agar) for 18&#x2013;20&#xa0;h at 37&#x20;&#xb1; 1&#xb0;C in a microaerobic environment. The broth microdilution assay was performed to determination the minimal inhibitory concentration (MIC) of BRP extracts. The broth microdilution assay was carried out in microplates (96 wells) and the procedure according to the Clinical and Laboratory Standards Institute (<xref ref-type="bibr" rid="B14">CLSI, 2012</xref>) and Rufatto et&#x20;al. (<xref ref-type="bibr" rid="B13">Celerino de Moraes Porto et&#x20;al., 2018</xref>). The microplates were prepared with 80&#xa0;&#xb5;l of brain heart infusion broth (BHI) and 80&#xa0;&#xb5;l of EBRP and EABRP at 2500&#xa0;&#x3bc;g/ml in each well groups from line A of the microplates, respectively. Serial two-fold dilutions was carried out to obtaining ethanol Brazilian red propolis and ethyl acetate Brazilian red propolis extracts at range from 1000&#xa0;&#x3bc;g/ml to 7.81&#xa0;&#x3bc;g/ml, respectively (<italic>n</italic>&#x20;&#x3d; 6). The inoculum was prepared by direct colonies suspension in sterile saline after strain activation period. A bacterial suspension was standardized equivalent to 0.5 McFarland standard suspension by turbidity comparison, resulting in a bacterial suspension containing approximately 1&#x20;&#xd7; 10<sup>8</sup> colony-forming units (CFU)/ml. The standardized inoculum suspension containing about 1&#x20;&#xd7;&#x20;10<sup>6</sup>&#xa0;CFU/ml was performed by dilution (1:20) of the 1&#x20;&#xd7;&#x20;10<sup>8</sup>&#xa0;CFU/ml bacterial suspension in sterile saline. Exactly 20&#xa0;&#xb5;l of the standardized inoculum suspension were added in each well, resulting a final bacterial concentration of 1&#x20;&#xd7; 10<sup>5</sup>&#xa0;CFU/ml, according CLSI (<xref ref-type="bibr" rid="B14">CLSI, 2012</xref>). The negative controls were A (inoculum &#x2b; medium) and B (inoculum &#x2b; medium &#x2b; 1.0% DMSO). The positive control was inoculum &#x2b; medium &#x2b;&#x20;0.12% chlorhexidine gluconate. The sterility control test was performed for BHI medium. The microplates were incubated in ambient air at 35&#x20;&#xb1; 2&#xb0;C for 20&#xa0;h. After microplates&#x2019; incubation, 5.0&#xa0;&#xb5;l of each well was pipetted and plated in Petri dishes containing sterile BHA for minimal bactericidal concentration (MBC) determination after new incubation period of 24&#xa0;h at 35&#x20;&#xb1;&#x20;2&#xb0;C. Exactly 20&#xa0;&#xb5;l of resazurin (7-hydroxy-10-oxidophenoxazin-10-ium-3-one) solution at 0.15&#xa0;mg/ml and pH 7.4 (50&#xa0;mM) were added in each well of the microplates that were incubated for more 2&#xa0;h at 35&#x20;&#xb1; 2&#xb0;C for observation of the bacterial growth. MIC values were defined as the lowest concentration where the well&#x2019;s color remained purple. The MBC values were defined as the lowest concentration where it did not colony growth visually.</p>
</sec>
<sec id="s2-2-4">
<title>Radical (DPPH)<sup>&#x2022;</sup> Scavenging Capacity (%RSC&#x2013;DPPH<sup>&#x2022;</sup>)</title>
<p>The radical scavenging capacity of the extracts were mensurated by DPPH<sup>
<bold>&#x2022;</bold>
</sup> method following the procedure described by <xref ref-type="bibr" rid="B57">Oliveira et&#x20;al. (2020)</xref>, with some modifications. Stock solutions of EBRP and EABRP were performed at 1.0&#xa0;mg/ml in absolute ethanol. Aliquots of EBRP were transferred to volumetric flask of 5.0&#xa0;ml, and then 2.0&#xa0;ml of DPPH solution (39.432&#xa0;&#x3bc;g/ml; in ethanol) was added obtaining final concentrations of 0.5, 1.0, 1.5, 2.0, 5.0, 10.0, 15.0, 20.0 and 25.0&#xa0;&#x3bc;g/ml, respectively (<italic>n</italic>&#x20;&#x3d; 3). The EABRP samples were obtained in the same way, but to final concentrations of 0.5, 1.0, 1.5, 2.0, 3.0 and 4.0&#xa0;&#x3bc;g/ml (<italic>n</italic>&#x20;&#x3d; 3). The scavenging reaction was performed in dark at 25&#xb0;C for 30&#xa0;min. After reaction time, the absorbance readings were performed with a spectrophotometer (Model UV-1240, Shimadzu, Kyoto, Japan) at 518&#xa0;nm and the solvent ethanol was used as blank. The percentage of radical-scavenging capacity (%RSC&#x2014;DPPH<sup>&#x2022;</sup>) of samples was calculated as follows:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext>%RSC&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>H</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>s</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>e</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mrow>
<mml:mi>D</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>H</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;&#x2a;&#xa0;</mml:mtext>
<mml:mn>100</mml:mn>
<mml:msqrt>
<mml:mrow>
<mml:msup>
<mml:mi>a</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>&#x2b;</mml:mo>
<mml:msup>
<mml:mi>b</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>A</italic>
<sub>
<italic>DPPH</italic>
</sub> is the absorbance of the diluted DPPH solution (2.0&#xa0;ml of DPPH at 39.432&#xa0;&#x3bc;g/ml to 5&#xa0;ml of ethanol); <italic>A</italic>
<sub>
<italic>sample</italic>
</sub> is the absorbance of the tested sample at specific concentration. The IC<sub>50</sub> was determined for EBRP and EABRP through of linear equations from its calibration curves y &#x3d; ax &#x2b; b, plotted by extract concentration <italic>vs.</italic> %RSC; where: x is the equivalent concentration to IC<sub>50</sub> of %RSC; y is the numeric value 50; a is the angular coefficient (slope) of specific line; b is the linear coefficient of specific line. The positive control was trolox (6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromene-2-carboxylic acid) (Sigma-Aldrich) at final concentration range from 0.25 to 4.0&#xa0;&#x3bc;g/ml in ethanol.</p>
</sec>
<sec id="s2-2-5">
<title>Total Flavonoids Content</title>
<p>The total flavonoid content (TFC) was determined by AlCl<sub>3</sub> method (<xref ref-type="bibr" rid="B81">Woisky and Salatino, 1998</xref>), with some modifications. Therefore, were performed methanolic stock solutions of 5% AlCl<sub>3</sub> (w/v), EABRP at 10&#xa0;mg/ml and quercetin (Sigma-Aldrich) at 1.0&#xa0;mg/ml, respectively. The assay was performed by add of aliquots of 10&#xa0;mg/ml EABRP and 100&#xa0;&#xb5;l of 5% AlCl<sub>3</sub> in a 5&#xa0;ml volumetric flask (methanol). The final concentration range of EABRP was from 50 to 200&#xa0;&#x3bc;g/ml (<italic>n</italic>&#x20;&#x3d; 3). The solutions absorbances were measured in a UV-Vis spectrophotometer set at the 425&#xa0;nm wavelength after 30&#xa0;min of incubation in dark room at 25&#xb0;C. Total flavonoids content was calculated using the quercetin calibration plot (Y &#x3d; 0.0711x &#x2b; 0.0027, <italic>R</italic>
<sup>2</sup> &#x3d; 0.999) and expressed as mg quercetin equivalent (QE) g<sup>&#x2212;1</sup> of dried EABRP extract.</p>
</sec>
</sec>
<sec id="s2-3">
<title>Preparation of Experimental Composite Samples</title>
<p>The composite resin Filtek&#x2122; Bulk Fill Flow (3M/ESPE, St. Paul, MN, United&#x20;States) color A2 was modified by addition of ethyl acetate Brazilian red propolis (EABRP) in 10&#xa0;&#xb5;l of 2-hydroxyethyl methacrylate (HEMA solvent) from Sigma-Aldrich (St. Louis. MO, United&#x20;States) for development of experimental groups. The composition of the commercial composite is described in <xref ref-type="table" rid="T1">Table&#x20;1</xref>. The commercial composite was used as a control group (RC). To test the HEMA solvent effect alone, 10&#xa0;&#x3bc;l of pure HEMA was added to commercial composite to obtaining the solvent control group (RS). The two controls were used at all characterization assays of enriched composites with Brazilian red propolis. The final concentrations of EABRP in the experimental composites were 0.10, 0.15, and 0.25% (w/v) to obtaining the experimental groups RP10, RP15 and RP25, respectively.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Filtek&#x2122; bulk fill flow (RC) composition.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Lot</th>
<th align="center">Color</th>
<th align="center">Organic matrix % (w/w)</th>
<th align="center">Filler % (w/w)</th>
<th align="center">Photoinitiators % (w/w)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="left">&#x23;1827100773</td>
<td rowspan="5" align="left">A2</td>
<td align="left">UDMA 10-20</td>
<td rowspan="2" align="left">Treated silanized ceramics 50-60</td>
<td align="left">Benzotriazole &#x3c; 1</td>
</tr>
<tr>
<td align="left">Substituted dimethacrylate 10-20</td>
<td align="left">EDMAB &#x3c; 1</td>
</tr>
<tr>
<td align="left">Bis-EMA 1-10</td>
<td rowspan="3" align="left">YbF<sub>3</sub> 1-10</td>
<td rowspan="3" align="left"/>
</tr>
<tr>
<td align="left">Bis-GMA 1-10</td>
</tr>
<tr>
<td align="left">TEGDMA &#x3c; 1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>UDMA, urethane dimethacrylate; Bis-EMA, bisphenol A ethoxylate dimethacrylate; Bis-GMA, Bisphenol A glycerolate dimethacrylate; TEGDMA, triethylene glycol dimethacrylate; YbF<sub>3</sub>, Ytterbium fluoride; EDMAB, Ethyl 4-(dimethylamino)benzoate.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Three EABRP stock solutions were prepared at concentrations of 10.0, 15.0 and 25.0&#xa0;mg/ml in HEMA solvent, and the mixture was homogenized by vortex in a dark room. The enriched composites resins groups were obtained by the addition of 10&#xa0;&#x3bc;l of the EABRP-HEMA solution in 100&#xa0;mg of the commercial composite resin and photoactivated for 20&#xa0;s using a curing light (LED Emitter A FIT, 1250&#xa0;mW/cm<sup>2</sup>, &#x3bb;max 455&#xa0;nm, light tip 8&#xa0;mm, Schuster, Santa Maria,&#x20;BRA).</p>
<p>The samples of experimental composites groups were prepared in molds with specific dimensions for each type of biological, mechanical, or physicochemical assays and positioned between two polyester strips. Before photoactivation, the upper surface of samples was covered with a glass blade and subjected to a load of 500&#xa0;g for 1&#xa0;min to remove excess material and ensure standardization of samples. The glass blade was removed to carry out the photoactivation. The Schematic representation of the process of obtaining and characterization of composite resin enriched with Brazilian red propolis is show in <xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S2</xref>.</p>
</sec>
<sec id="s2-4">
<title>Biologic Characterization of Composite Resin Enriched With Brazilian Red Propolis</title>
<sec id="s2-4-1">
<title>Antibacterial Activity (Direct Contact Test)</title>
<p>Five disc-shaped samples to each experimental group were prepared with the aid of a stainless metallic matrix (h &#x3d;&#x20;1.0&#xa0;mm, &#xd8; &#x3d; 5.0&#xa0;mm) and then were photoactivated for 20&#xa0;s, as describe previously. The antibacterial activity of experimental composites was determined in relation to the <italic>Streptococcus mutans</italic> CCT 3440 strain. The bacterial strain was activated in sterile BHI medium at 37&#xb0;C for 24&#xa0;h, and then sowed in BHA medium and incubated at 37&#xb0;C for 18&#xa0;h. The inoculum concentration was adjusted in sterile physiologic solution from colonies isolated in BHA. The inoculum was adjusted to 10<sup>6</sup> UFC/ml for the determination of antibacterial activity by direct contact&#x20;test.</p>
<p>The antibacterial activity of experimental composite RP25 was also determined by direct contact test (<xref ref-type="bibr" rid="B75">Tavassoli Hojati et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B84">Zhang et&#x20;al., 2017</xref>). Therefore, 10&#xa0;&#x3bc;l of suspended bacteria (10<sup>6</sup> UFC/ml) were placed on each disc-shaped sample (&#xf8; &#x3d;&#x20;5&#xa0;mm; thickness &#x3d; 1.0&#xa0;mm) individually positioned in sterile microtubes (<italic>n</italic>&#x20;&#x3d; 5). The disc-shaped sample in contact with inoculum were maintained laminar flow, for 1&#xa0;h, until the entire liquid suspension evaporated to obtain a thin layer of bacteria. After this period, 200&#xa0;&#x3bc;l of sterile physiologic solution was added to the each microtubes and the bacterial suspension was homogenized in vortex. To estimate colony formation, bacterial suspension from each specimen was diluted in sterile physiologic solution at 1:10 (10<sup>&#x2212;1</sup>) proportion, then 25&#xa0;&#x3bc;l of this dilution was inoculated in BHA plates for 24&#xa0;h at 37&#x20;&#xb1; 1&#xb0;C in a microaerobic environment. After incubation, the total colonies were counted (<italic>n</italic>&#x20;&#x3d; 5) and the determination of UFC/ml were performed to each group, using the equation:<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mtext>UFC</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>ml&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;N&#xba;&#xa0;of&#xa0;colonies&#xa0;x&#xa0;</mml:mtext>
<mml:mn>40</mml:mn>
<mml:mtext>&#xa0;x&#xa0;</mml:mtext>
<mml:mn>10</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>Where: N&#xba; of colonies is the total colonies present the plate after direct contact test; 40 is the correction factor to 1&#xa0;ml (25&#xa0;&#x3bc;l &#xd7; 40&#x20;&#x3d;&#x20;1&#xa0;ml); 10 is the modulus of dilution used (10<sup>&#x2212;1</sup>) to UFC/ml count. The group RC (commercial composite) was used as negative control. The group RS (commercial composite with the solvent HEMA) was used to evaluate the solvent effect in enriched composite resins formulations. A microtube with inoculum without composites was used as cell control. Antibacterial activity was expressed by antibacterial ratio, where:<disp-formula id="equ3">
<mml:math id="m3">
<mml:mrow>
<mml:mtext>r&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mtext>%</mml:mtext>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>b&#xa0;</mml:mtext>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>&#xa0;c</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#xa0;b</mml:mtext>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;x&#xa0;</mml:mtext>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>Where r (%) is the antibacterial ratio; b is the average UFC/ml recovered for bacterial control; c is the average of recovered UFC/ml for the experimental&#x20;group.</p>
</sec>
<sec id="s2-4-2">
<title>Cytotoxicity</title>
<p>The <italic>in&#x20;vitro</italic> cytotoxicity assay was performed for determined the cytotoxicity of BRP enriched composite resin against 3T3 fibroblasts. The composite samples were prepared as describe previously, and 24&#xa0;h later the samples were immersed in pure Dulbecco&#x2019;s Modified Eagle Medium (DMEM) medium, incubated for 24&#xa0;h at 37&#xb0;C, 5% CO<sub>2</sub> and 95% relative humidity to obtain the extracts (composite resins extracts in DMEM). The extracts were prepared at the ratio of 1.0, 2.0, 3.0, 5.0 and 6.0&#xa0;cm<sup>2</sup> of composite/mL of medium to the experimental groups analyzed RC, RS and RP25 (<italic>n</italic>&#x20;&#x3d; 5), according to ISO 10993-12 (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2006</xref>). The samples were taken from the culture medium after the specified time and the obtained extracts were filtered in 0.22&#xa0;&#x3bc;m membranes (Millipore, Molsheim, France) to ensure sterile conditions.</p>
<p>Fibroblasts of the 3T3 strain (embryonic fibroblasts of mice) were sown in DMEM medium supplemented with 10% bovine fetal serum (SBF), L-glutamine (2.0&#xa0;&#x3bc;M) and penicillin/streptomycin (0.02&#xa0;&#x3bc;g/ml) and were kept at 37&#xb0;C, 5% CO<sub>2</sub> and 95% relative humidity. The cells were transferred to 96-well plates (200&#xa0;&#x3bc;l/well&#x2014;7.0 &#xd7; 10<sup>3</sup> cells/ml of complete culture medium) and incubated for 24&#xa0;h in the same conditions as described previously. After this period, the supernatant was removed and each well with cells received 180&#xa0;&#x3bc;l of fresh complete DMEM and 20.0&#xa0;&#x3bc;l of the extract, and the cells were incubated for 24&#xa0;h under the same conditions of temperature, CO<sub>2</sub> and humidity. The negative control group (cell control) received only fresh complete DMEM. Cell viability was determined by the MTT assay [3-bromide (3,5-dimetiltiazole-2-yl)-2,5-diphenyltrazzole] 24&#xa0;h after exposure of cells to composite resins extracts in DMEM. The cells were washed with phosphate buffered saline (PBS) and 23&#xa0;&#x3bc;l of an MTT solution (5.0&#xa0;mg/ml in PBS) were added to each well as well as 23&#xa0;&#x3bc;l of an MTT solution (5.0&#xa0;mg/ml in PBS), then the cells were incubated again for 4&#xa0;h under the same conditions. The supernatant was discarded and 150&#xa0;&#x3bc;l dimethyl sulfoxide (DMSO) was added to each well to dissolve the formazan crystals. After 10&#xa0;min the optical density of the resulting solution was read at 540&#xa0;nm in a spectrophotometer (Model UV-1240, Shimadzu, Kyoto, Japan). The mean values of optical density obtained from cells exposed to DMEM were used as a negative control reference (100% cell survival). The cytotoxicity of the tested samples was expressed as the percentage of cell viability in relation to the negative control (100%), (<italic>n</italic>&#x20;&#x3d; 5). The <italic>in&#x20;vitro</italic> cytotoxicity was determined by decrease of the cell viability as the equation:<disp-formula id="equ4">
<mml:math id="m4">
<mml:mrow>
<mml:mtext>Cell&#xa0;viability&#xa0;%&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>100</mml:mn>
<mml:mtext>&#xa0;x&#xa0;</mml:mtext>
<mml:mi>O</mml:mi>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mn>540</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mtext>&#xa0;sample</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mi>O</mml:mi>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mn>540</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>&#xa0;</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>where OD<sub>540sample</sub> is the optical density of cells after sample treatment and OD<sub>540 cell control</sub> is the optical density of cells control&#x20;group.</p>
</sec>
</sec>
<sec id="s2-5">
<title>Mechanical Characterization</title>
<sec id="s2-5-1">
<title>Three-Point Flexural Strength (ISO 4049)</title>
<p>Rectangular samples were made for each experimental group (<italic>n</italic>&#x20;&#x3d;&#x20;10) in a stainless-steel matrix (2&#xa0;mm &#xd7; 2&#xa0;mm x 25&#xa0;mm) according to the specifications of ISO 4049 (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2000</xref>) and then were photoactivated for 20&#xa0;s, as describe previously. The photoactivation process was carryout according to the ISO 4049 specifications: one moment of photoactivation for each of the three points on top and bottom samples surfaces. After cure, the samples were kept in distilled water at 37&#xb0;C for 24&#xa0;h before test. The test was performed in a Microtensile/Semi-universal OM100 test machine (Odeme Dental Research, SC, BRA) with two rods (2&#xa0;mm in diameter), mounted parallel with 20&#xa0;mm between its centres, and a third rod (2&#xa0;mm in diameter) centred between, and parallel to, the other two. The loading ratio and speed applied on samples was of 50&#xa0;N/min and 0.75&#x20;&#xb1; 0.25&#xa0;mm/min, respectively, according to ISO 4049 until the sample fracture. Flexural strength (FS) was expressed in MPa by equation:<disp-formula id="equ5">
<mml:math id="m5">
<mml:mrow>
<mml:mtext>FS&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mn>3</mml:mn>
<mml:mi>F</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>/</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>b</mml:mi>
<mml:msup>
<mml:mi>h</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>F</italic> is the maximum load, in newtons, exerted on the sample; <italic>l</italic> is the distance, in millimeters, between the supports; <italic>b</italic> is the width, in millimeters, of the specimen measured immediately prior to testing and <italic>h</italic> is the height, in millimeters, of the specimen measured immediately prior to testing.</p>
</sec>
<sec id="s2-5-2">
<title>Knoop Microhardness</title>
<p>Five disc-shaped samples were made for each group, with the aid of a stainless metallic matrix (h &#x3d; 1.0&#xa0;mm, &#xd8; &#x3d; 5.0&#xa0;mm) and then were photoactivated for 20&#xa0;s, as describe previously. The samples were stored in distilled water at 37&#xb0;C for 24&#xa0;h before test. Five indentations were performed on the irradiated surface of each sample at the center and more four regions with a load of 50&#xa0;g for 5&#xa0;s using an HMV-2000 microhardness (Shimadzu, Tokyo, Japan). The average of five indentations was taken as KHN to each of four samples on each experimental group and the average of four KHN in each experimental group was taken as the KHN to the group. The Knoop microhardness (KHN) was determined by equation:<disp-formula id="equ6">
<mml:math id="m6">
<mml:mrow>
<mml:mi>K</mml:mi>
<mml:mi>H</mml:mi>
<mml:mi>N</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>/</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>C</mml:mi>
<mml:msup>
<mml:mi>L</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
</disp-formula>where <italic>P</italic> is the load applied on the sample (Kgf); <italic>L</italic> is the length of the longest diagonal of the indentation (mm<sup>2</sup>) and <italic>C</italic> is the indentation constant (0.07028).</p>
</sec>
</sec>
<sec id="s2-6">
<title>Physicochemical Characterization</title>
<sec id="s2-6-1">
<title>Post-Cure Depth</title>
<p>The post-cure depth was determined according to ISO 4049 procedure specifications (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2000</xref>). Five cylindric-shaped samples per group were produced with the aid of a cylindrical stainless metallic matrix (h &#x3d; 6.0&#xa0;mm, &#xd8; &#x3d; 2.0&#xa0;mm) and then were photoactivated for 20&#xa0;s, as describe previously. Then, the samples were immediately removed from the matrix and the uncured material at the bottom surface was scraped with a plastic spatula. The height of the cylindric-shaped samples was measured with a micrometer (with an accuracy of 0.01&#xa0;mm) after scraping. The post-cure depth to each experimental groups was determined as the mean of each group samples.</p>
</sec>
<sec id="s2-6-2">
<title>Degree of Conversion</title>
<p>The degree of conversion of the experimental groups was analyzed by Fourier transform infrared spectroscopy (FTIR; IRAffinity-1 Model, Shimadzu, Kyoto, Japan) in attenuated total reflection (ATR) mode. The DC% was measuring by change of height of the band at 1638&#xa0;cm<sup>&#x2212;1</sup> (corresponding with the aliphatic carbon double bond absorbance). The aromatic carbon double bond absorbance at 1608&#xa0;cm<sup>&#x2212;1</sup> was used as standard control. Each sample spectrum was acquired with 64 scans, resolution of 4.0&#xa0;cm<sup>&#x2212;1</sup> and using the absorbance mode. Disc-shaped samples were made with the aid of a stainless metallic matrix (h &#x3d; 1.0&#xa0;mm, &#xd8; &#x3d; 5.0&#xa0;mm) and then were photoactivated for 20&#xa0;s, as describe previously. Were analyzed non-polymerized samples (<italic>n</italic>&#x20;&#x3d; 3), immediately polymerized samples (<italic>n</italic>&#x20;&#x3d; 3) and samples with 24&#xa0;h after polymerization (<italic>n</italic>&#x20;&#x3d; 3) to each experimental group and theirs respective FTIR spectra were obtained. The degree of conversion was calculated as follows:<disp-formula id="equ7">
<mml:math id="m7">
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>DC%</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mtext>R</mml:mtext>
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>/</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mtext>R</mml:mtext>
<mml:mrow>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>]</mml:mo>
<mml:mtext>x&#xa0;</mml:mtext>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>where: R &#x3d; (band at 1638&#xa0;cm<sup>&#x2212;1</sup>)/(band at 1608&#xa0;cm<sup>&#x2212;1</sup>).</p>
</sec>
<sec id="s2-6-3">
<title>Water Sorption and Water Solubility</title>
<p>The water sorption (Wsp) and water solubility (Wsl) in water of the experimental resins were determined according to ISO 4049 specifications (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2000</xref>). Five samples (h &#x3d; 1.0&#xa0;mm, &#xd8; &#x3d; 15.0&#xa0;mm) per experimental group were prepared in a stainless metallic matrix and were photoactivated at nine points on the upper surface, each point for 20&#xa0;s. After photoactivation, the samples were arranged in a light-proof container for 24&#xa0;h and transferred to a desiccator containing silica gel dehydrated (Fischer Scientific<sup>&#xae;</sup>, Leicester, United&#x20;Kingdom), this set was kept at 37&#xb0;C in an oven. After 22&#xa0;h, all groups were transferred to a second desiccator, where they were kept for 2&#xa0;h at 37&#xb0;C. At the end of the cycle, each sample was weighed on an analytical balance with precision of 0.01&#xa0;mg (Ohaus<sup>&#xae;</sup> DV314C Discovery, Pine Brook, United&#x20;States) and replaced in the initial desiccator. The cycles were repeated until a constant mass was reached M1 (&#x3bc;g), so that the weight variability was not greater than 0.1&#xa0;mg in 24&#xa0;h period. The samples were measured with digital micrometer (accurate to 0.01&#xa0;mm, DIGIMESS-110-250, Digimess<sup>&#xae;</sup> Precision Instruments Ltda, SP, BR) in order to determine the area (mm<sup>2</sup>) and volume (mm<sup>3</sup>). Then, the samples were immersed in water at 37&#x20;&#xb1; 1&#xb0;C (Fanem<sup>&#xae;</sup> Water Bath 1100, SP, BR), for 7&#xa0;days. After this period, excess water was removed, and each sample again weighed. The wet mass was recorded as M2 (&#x3bc;g). The design cycles were repeated, as previously described, until the stable weight was reached, corresponding to M3 (&#x3bc;g). The mean values of Wsp and Wsl of each sample were calculated in micrograms per cubic millimeter using equations, respectively:<disp-formula id="equ8">
<mml:math id="m8">
<mml:mrow>
<mml:mtext>Wsp&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>M</mml:mtext>
<mml:mn>2</mml:mn>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#xa0;M</mml:mtext>
<mml:mn>3</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mtext>V</mml:mtext>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="equ9">
<mml:math id="m9">
<mml:mrow>
<mml:mtext>Wsl&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>M</mml:mtext>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>M</mml:mtext>
<mml:mn>3</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mtext>V</mml:mtext>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-6-4">
<title>Roughness Analysis</title>
<p>Disc-shaped samples were made with the aid of a stainless metallic matrix (h &#x3d; 1.0&#xa0;mm, &#xd8; &#x3d; 5.0&#xa0;mm) and then were photoactivated for 20&#xa0;s, as describe previously. The average surface roughness (Ra) was determined by an atomic force microscopy (AFM) (Model Multiview 4000TM, Nanonics, Jerusalem, Israel) combined with optical microscope (Model BXFM Olympus, Tokyo, Japan). The AFM system was acoustically isolated, and the instrument was stabilized on an active table of movements. The topography of the samples was determined (256 &#xd7; 256 pixels) in tapping mode with a scan ratio of 0.3&#x2013;1.0&#xa0;Hz in an area of 20&#x20;&#xd7; 20&#xa0;&#x3bc;m. The probe has a diameter &#x3c;10&#xa0;nm, 300&#xa0;&#xb5;m cantilever, 30&#xb0; bend angle, 32&#xa0;kHz resonance frequency and a Cr coating. Twelve regions per experimental group were analyzed and the average roughness (Ra) was determined using the Software WSxM (Nanotec, Madrid, Spain). The roughness average was calculated as the absolute mean of the heights of the irregularities along the profile as the equation:<disp-formula id="equ10">
<mml:math id="m10">
<mml:mrow>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mi>N</mml:mi>
</mml:mfrac>
<mml:munderover>
<mml:mstyle displaystyle="true">
<mml:mo>&#x2211;</mml:mo>
</mml:mstyle>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>N</mml:mi>
</mml:munderover>
<mml:mo>&#x7c;</mml:mo>
<mml:msub>
<mml:mi>z</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>z</mml:mi>
<mml:mo>&#xaf;</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mo>&#x7c;</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>Where: N is the number of sample points, z<sub>i</sub> is the height of each sample point and <inline-formula id="inf1">
<mml:math id="m11">
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>Z</mml:mtext>
<mml:mo>&#xaf;</mml:mo>
</mml:mover>
</mml:mrow>
<mml:mo>&#xa0;</mml:mo>
</mml:mrow>
</mml:math>
</inline-formula>is the average height of the sample points.</p>
</sec>
<sec id="s2-6-5">
<title>Thermal Analysis (TGA e DSC)</title>
<p>Five disc-shaped samples were prepared in a stainless metallic matrix (h &#x3d; 1.0&#xa0;mm, &#xd8; &#x3d; 5.0&#xa0;mm) and powdered to obtain uniform powder. Thermogravimetry analysis (TGA) was performed in a TGA-51H model equipment (Shimadzu, Kyoto, Japan), from 4.5&#xa0;mg&#x20;&#xb1; 6.6% of each sample, packed in alumina crucible. The heating ratio was 10&#xb0;C&#xa0;min<sup>&#x2212;1</sup> in the range of 25&#x2013;900&#xb0;C in nitrogen atmosphere with flow of 50&#xa0;cm<sup>3</sup>&#xa0;min<sup>&#x2212;1</sup>. The equipment was calibrated under the same conditions with calcium oxalate monohydrate pattern. Differential scanning calorimetry analysis (DSC) was performed in DSC model 60 plus (Shimadzu, Kyoto, Japan) from 2.5&#xa0;mg&#x20;&#xb1; 4.0% of each sample packed in hermetically sealed alumina crucible. The heating ratio was 5.0&#xb0;C&#xa0;min<sup>&#x2212;1</sup> in the range of 30&#x2013;600&#xb0;C in nitrogen atmosphere and flow of 50&#xa0;cm<sup>3</sup>&#xa0;min<sup>&#x2212;1</sup>. The equipment was calibrated under the same conditions with indium and&#x20;zinc.</p>
</sec>
</sec>
<sec id="s2-7">
<title>Statistical Analysis</title>
<p>The statistical analysis was performed using the software GraphPad prism 9.2.0. The Shapiro-Wilk test was performed to determine the normality distribution of results data, at the level of significance of 95%. The parametric data were analyzed by one-way analysis of variance ANOVA followed by Tukey&#x2019;s comparisons test (<italic>p</italic>&#x20;&#x3c; 0.05). The data of cytotoxicity assay of were analyzed by two-way ANOVA followed by Tukey&#x2019;s comparisons test (<italic>p</italic>&#x20;&#x3c; 0.05). The non-parametric data were analyzed by Kruskal-Wallis test followed by Dunn&#x2019;s comparisons post-test at the level of significance of 95% (<italic>p</italic>&#x20;&#x3d;&#x20;0.05).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Chemical Characterization and Antibacterial Activity of Brazilian Red Propolis Extracts</title>
<p>The BRP chemical composition was identified by LC-ESI-Orbitrap-FTMS, where was possible to identify fifty compounds from BRP belonging to the class of phenolic acids, flavonoids (isoflavones, isoflavans, flavones, flavanonols, flavonols, flavanols, flavanones, C30 isoflavones, pterocarpan), chalcones, triterpenes and prenylated benzophenones. The EABRP LC-ESI-Orbitrap-FTMS chromatogram shows in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>. Furthermore, is observed that the compounds 4,4&#x2032;-dihydroxy-2-methoxychalcone (26), formononetin (23), formononetin (22), vestitol (28), liquiritigenin (13), and isoliquiritigenin (21) are the major constituents of this EABRP extract. The identified compounds in the EABRP extract are listed in <xref ref-type="table" rid="T2">Table&#x20;2</xref>. The chemical structures of some of compounds identified from EABRP are show in the <xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>EABRP LC-ESI-Orbitrap-FTMS chromatogram.</p>
</caption>
<graphic xlink:href="fphar-12-787633-g001.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Identification and confirmation of some markers of the EABRP using LC-ESI- Orbitrap-FTMS.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Peak</th>
<th align="center">RT (min.)</th>
<th align="center">[M-H]<sup>-</sup> (m/z)</th>
<th align="center">MW</th>
<th align="center">Formulae</th>
<th align="center">Compound</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="char" char=".">2.95</td>
<td align="char" char=".">179.0556</td>
<td align="char" char=".">180.16</td>
<td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub>
</td>
<td align="left">Caffeic acid</td>
</tr>
<tr>
<td align="left">2</td>
<td align="char" char=".">2.98</td>
<td align="char" char=".">193.0502</td>
<td align="char" char=".">194.18</td>
<td align="left">C<sub>10</sub>H<sub>10</sub>O<sub>4</sub>
</td>
<td align="left">Ferulic acid</td>
</tr>
<tr>
<td align="left">3</td>
<td align="char" char=".">3.00</td>
<td align="char" char=".">178.0556</td>
<td align="char" char=".">179.05</td>
<td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>4</sub>
</td>
<td align="left">Umbelic acid</td>
</tr>
<tr>
<td align="left">4</td>
<td align="char" char=".">3.04</td>
<td align="char" char=".">163.0243</td>
<td align="char" char=".">164.16</td>
<td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>3</sub>
</td>
<td align="left">p-coumaric acid</td>
</tr>
<tr>
<td align="left">5</td>
<td align="char" char=".">3.10</td>
<td align="char" char=".">475.1232</td>
<td align="char" char=".">476.43</td>
<td align="left">C<sub>23</sub>H<sub>24</sub>O<sub>11</sub>
</td>
<td align="left">7-O-beta-glucopyranosyl-4&#x2032;-hydroxy-5-methoxyisoflavone</td>
</tr>
<tr>
<td align="left">6</td>
<td align="char" char=".">4.50</td>
<td align="char" char=".">461.1023</td>
<td align="char" char=".">462.40</td>
<td align="left">C<sub>22</sub>H<sub>22</sub>O<sub>11</sub>
</td>
<td align="left">6-Methoxyluteolin 7-rhamnoside</td>
</tr>
<tr>
<td align="left">7</td>
<td align="char" char=".">7.05</td>
<td align="char" char=".">269.0811</td>
<td align="char" char=".">270.24</td>
<td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>5</sub>
</td>
<td align="left">Genistein</td>
</tr>
<tr>
<td align="left">8</td>
<td align="char" char=".">7.35</td>
<td align="char" char=".">285.0395</td>
<td align="char" char=".">286.24</td>
<td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>5</sub>
</td>
<td align="left">Kaempferol</td>
</tr>
<tr>
<td align="left">9</td>
<td align="char" char=".">8.04</td>
<td align="char" char=".">289.0711</td>
<td align="char" char=".">290.27</td>
<td align="left">C<sub>15</sub>H<sub>14</sub>O<sub>6</sub>
</td>
<td align="left">Cathechin</td>
</tr>
<tr>
<td align="left">10</td>
<td align="char" char=".">8.28</td>
<td align="char" char=".">287.0553</td>
<td align="char" char=".">288.25</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>6</sub>
</td>
<td align="left">Dalbergioidin</td>
</tr>
<tr>
<td align="left">11</td>
<td align="char" char=".">8.83</td>
<td align="char" char=".">289.0711</td>
<td align="char" char=".">290.27</td>
<td align="left">C<sub>15</sub>H<sub>14</sub>O<sub>6</sub>
</td>
<td align="left">Epicatechin</td>
</tr>
<tr>
<td align="left">12</td>
<td align="char" char=".">8.95</td>
<td align="char" char=".">253.0499</td>
<td align="char" char=".">254.24</td>
<td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>4</sub>
</td>
<td align="left">Daidzein</td>
</tr>
<tr>
<td align="left">13</td>
<td align="char" char=".">9.70</td>
<td align="char" char=".">255.0654</td>
<td align="char" char=".">256.27</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>4</sub>
</td>
<td align="left">Liquiritigenin</td>
</tr>
<tr>
<td align="left">14</td>
<td align="char" char=".">10.5</td>
<td align="char" char=".">283.0384</td>
<td align="char" char=".">284.26</td>
<td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>5</sub>
</td>
<td align="left">2&#x2032;-Hydroxyformononetin</td>
</tr>
<tr>
<td align="left">15</td>
<td align="char" char=".">11.3</td>
<td align="char" char=".">331.0810</td>
<td align="char" char=".">332.30</td>
<td align="left">C<sub>17</sub>H<sub>16</sub>O<sub>7</sub>
</td>
<td align="left">Evernic acid</td>
</tr>
<tr>
<td align="left">16&#x2013;17</td>
<td align="char" char=".">11.9</td>
<td align="char" char=".">271.0602</td>
<td align="char" char=".">272.25</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>5</sub>
</td>
<td align="left">Narigenin/Pinobanksin</td>
</tr>
<tr>
<td align="left">18</td>
<td align="char" char=".">12.4</td>
<td align="char" char=".">285.0758</td>
<td align="char" char=".">286.24</td>
<td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>6</sub>
</td>
<td align="left">Calycosin</td>
</tr>
<tr>
<td align="left">19</td>
<td align="char" char=".">12.8</td>
<td align="char" char=".">521.1600</td>
<td align="char" char=".">522.173</td>
<td align="left">C<sub>32</sub>H<sub>26</sub>O<sub>7</sub>
</td>
<td align="left">Retusapurpurin B</td>
</tr>
<tr>
<td align="left">20</td>
<td align="char" char=".">13.2</td>
<td align="char" char=".">521.1600</td>
<td align="char" char=".">522.173</td>
<td align="left">C<sub>32</sub>H<sub>26</sub>O<sub>7</sub>
</td>
<td align="left">Retusapurpurin A</td>
</tr>
<tr>
<td align="left">21</td>
<td align="char" char=".">13.4</td>
<td align="char" char=".">255.0654</td>
<td align="char" char=".">256.27</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>4</sub>
</td>
<td align="left">Isoliquiritigenin</td>
</tr>
<tr>
<td align="left">22&#x2013;23</td>
<td align="char" char=".">13.77</td>
<td align="char" char=".">267.0655</td>
<td align="char" char=".">268.28</td>
<td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>4</sub>
</td>
<td align="left">Formononetin/Isoformononetin</td>
</tr>
<tr>
<td align="left">24</td>
<td align="char" char=".">15.5</td>
<td align="char" char=".">253.087</td>
<td align="char" char=".">254.28</td>
<td align="left">C<sub>16</sub>H<sub>14</sub>O<sub>3</sub>
</td>
<td align="left">6-Methoxyflavanone</td>
</tr>
<tr>
<td align="left">25</td>
<td align="char" char=".">15.5</td>
<td align="char" char=".">287.056</td>
<td align="char" char=".">288.25</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>6</sub>
</td>
<td align="left">6-Hidroxynaringenin</td>
</tr>
<tr>
<td align="left">26</td>
<td align="char" char=".">14.2</td>
<td align="char" char=".">269.0812</td>
<td align="char" char=".">270.28</td>
<td align="left">C<sub>16</sub>H<sub>14</sub>O<sub>4</sub>
</td>
<td align="left">4,4&#x2032;-dihydroxy-2-methoxychalcone</td>
</tr>
<tr>
<td align="left">27</td>
<td align="char" char=".">14.2</td>
<td align="char" char=".">269.0812</td>
<td align="char" char=".">270.32</td>
<td align="left">C<sub>16</sub>H<sub>14</sub>O<sub>4</sub>
</td>
<td align="left">(7S)-dalbergiphenol</td>
</tr>
<tr>
<td align="left">28</td>
<td align="char" char=".">14.66</td>
<td align="char" char=".">271.0603</td>
<td align="char" char=".">272.29</td>
<td align="left">C<sub>16</sub>H<sub>16</sub>O<sub>4</sub>
</td>
<td align="left">Vestitol</td>
</tr>
<tr>
<td align="left">29</td>
<td align="char" char=".">15.10</td>
<td align="char" char=".">269.0813</td>
<td align="char" char=".">270.28</td>
<td align="left">C<sub>16</sub>H<sub>14</sub>O<sub>4</sub>
</td>
<td align="left">Pinostrobin</td>
</tr>
<tr>
<td align="left">30</td>
<td align="char" char=".">15.10</td>
<td align="char" char=".">269.0813</td>
<td align="char" char=".">270.27</td>
<td align="left">C<sub>16</sub>H<sub>14</sub>O<sub>4</sub>
</td>
<td align="left">Medicarpin</td>
</tr>
<tr>
<td align="left">31</td>
<td align="char" char=".">16.2</td>
<td align="char" char=".">271.0607</td>
<td align="char" char=".">272.29</td>
<td align="left">C<sub>16</sub>H<sub>16</sub>O<sub>4</sub>
</td>
<td align="left">2&#x2032;,6&#x2032;-dihydroxy-4&#x2032;-methoxydihydrochalcone</td>
</tr>
<tr>
<td align="left">32</td>
<td align="char" char=".">16.2</td>
<td align="char" char=".">283.0657</td>
<td align="char" char=".">284.26</td>
<td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>5</sub>
</td>
<td align="left">Thevetiaflavone</td>
</tr>
<tr>
<td align="left">33</td>
<td align="char" char=".">16.42</td>
<td align="char" char=".">283.0603</td>
<td align="char" char=".">284.26</td>
<td align="left">C<sub>16</sub>H<sub>12</sub>O<sub>5</sub>
</td>
<td align="left">Biochanin A</td>
</tr>
<tr>
<td align="left">34</td>
<td align="char" char=".">16.73</td>
<td align="char" char=".">253.0865</td>
<td align="char" char=".">254.25</td>
<td align="left">C<sub>15</sub>H<sub>10</sub>O<sub>4</sub>
</td>
<td align="left">Chrysin</td>
</tr>
<tr>
<td align="left">35</td>
<td align="char" char=".">16.87</td>
<td align="char" char=".">255.1019</td>
<td align="char" char=".">256.27</td>
<td align="left">C<sub>15</sub>H<sub>12</sub>O<sub>4</sub>
</td>
<td align="left">Pinocembrin</td>
</tr>
<tr>
<td align="left">36</td>
<td align="char" char=".">17.0</td>
<td align="char" char=".">539.1699</td>
<td align="char" char=".">540.56</td>
<td align="left">C<sub>32</sub>H<sub>28</sub>O<sub>8</sub>
</td>
<td align="left">3&#x2032;,4&#x2032;-di-O-benzyl-7-O-(2-hydroxyethyl)-3-O-methylquercetin</td>
</tr>
<tr>
<td align="left">37</td>
<td align="char" char=".">17.9</td>
<td align="char" char=".">285.113</td>
<td align="char" char=".">286.32</td>
<td align="left">C<sub>17</sub>H<sub>18</sub>O<sub>4</sub>
</td>
<td align="left">Sativan</td>
</tr>
<tr>
<td align="left">38</td>
<td align="char" char=".">18.2</td>
<td align="char" char=".">285.1131</td>
<td align="char" char=".">286.32</td>
<td align="left">C<sub>17</sub>H<sub>18</sub>O<sub>4</sub>
</td>
<td align="left">(3S)-7-O-methylvestitol</td>
</tr>
<tr>
<td align="left">39</td>
<td align="char" char=".">18.2</td>
<td align="char" char=".">285.1131</td>
<td align="char" char=".">286.32</td>
<td align="left">C<sub>17</sub>H<sub>18</sub>O<sub>4</sub>
</td>
<td align="left">7,3&#x2032;-Dihydroxy-4&#x2032;-methoxy-8-methylflavane</td>
</tr>
<tr>
<td align="left">40</td>
<td align="char" char=".">21.4</td>
<td align="char" char=".">425.1603</td>
<td align="char" char=".">426.71</td>
<td align="left">C<sub>30</sub>H<sub>50</sub>O</td>
<td align="left">Cycloartenol/&#x3b1;-amyrin/&#x3b2;-amyrin</td>
</tr>
<tr>
<td align="left">41</td>
<td align="char" char=".">23.6</td>
<td align="char" char=".">533.2906</td>
<td align="char" char=".">534.69</td>
<td align="left">C<sub>33</sub>H<sub>42</sub>O<sub>6</sub>
</td>
<td align="left">Hyperibone H</td>
</tr>
<tr>
<td align="left">42</td>
<td align="char" char=".">25.5</td>
<td align="char" char=".">617.3480</td>
<td align="char" char=".">618.82</td>
<td align="left">C<sub>38</sub>H<sub>50</sub>O<sub>7</sub>
</td>
<td align="left">16-hidroxiguttiferone K</td>
</tr>
<tr>
<td align="left">43</td>
<td align="char" char=".">27.3</td>
<td align="char" char=".">511.1383</td>
<td align="char" char=".">512.50</td>
<td align="left">C<sub>30</sub>H<sub>24</sub>O<sub>8</sub>
</td>
<td align="left">Rhuschalcone V</td>
</tr>
<tr>
<td align="left">44</td>
<td align="char" char=".">32.80</td>
<td align="char" char=".">601.3533</td>
<td align="char" char=".">602.80</td>
<td align="left">C<sub>38</sub>H<sub>50</sub>O<sub>6</sub>
</td>
<td align="left">Guttiferone F</td>
</tr>
<tr>
<td align="left">45</td>
<td align="char" char=".">32.88</td>
<td align="char" char=".">601.3533</td>
<td align="char" char=".">602.80</td>
<td align="left">C<sub>38</sub>H<sub>50</sub>O<sub>6</sub>
</td>
<td align="left">Xantochymol</td>
</tr>
<tr>
<td align="left">46</td>
<td align="char" char=".">32.90</td>
<td align="char" char=".">601.3533</td>
<td align="char" char=".">602.80</td>
<td align="left">C<sub>38</sub>H<sub>50</sub>O<sub>6</sub>
</td>
<td align="left">Guttiferone E</td>
</tr>
<tr>
<td align="left">47</td>
<td align="char" char=".">34.10</td>
<td align="char" char=".">347.2233</td>
<td align="char" char=".">348.52</td>
<td align="left">C<sub>22</sub>H<sub>36</sub>O<sub>3</sub>
</td>
<td align="left">Anacardic acid (6-pentadecylsalycilic acid)</td>
</tr>
<tr>
<td align="left">48</td>
<td align="char" char=".">39.24</td>
<td align="char" char=".">669.4355</td>
<td align="char" char=".">670.917</td>
<td align="left">C<sub>43</sub>H<sub>58</sub>O<sub>6</sub>
</td>
<td align="left">Guttiferone C</td>
</tr>
<tr>
<td align="left">49</td>
<td align="char" char=".">39.24</td>
<td align="char" char=".">669.4355</td>
<td align="char" char=".">670.917</td>
<td align="left">C<sub>43</sub>H<sub>58</sub>O<sub>6</sub>
</td>
<td align="left">Guttiferone D</td>
</tr>
<tr>
<td align="left">50</td>
<td align="char" char=".">39.24</td>
<td align="char" char=".">669.4355</td>
<td align="char" char=".">670.917</td>
<td align="left">C<sub>43</sub>H<sub>58</sub>O<sub>6</sub>
</td>
<td align="left">Guttiferone B</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>RT, Retention time (min); MW, Molecular weight.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The quantification of seven markers from EABRP was performed by UPLC-DAD. The flavonoids daidzein, liquiritigenin, pinobanksin, formononetin, pinocembrin, biochanin A and the chalcone isoliquiritigenin were identified and quantified from EABRP dried extract. Its respective concentrations are showed in <xref ref-type="table" rid="T3">Table&#x20;3</xref>. The EABRP UPLC-DAD chromatogram too shows formononetin, liquiritigenin and isoliquiritigenin as majority compounds of EABRP dried extract <xref ref-type="fig" rid="F2">Figure&#x20;2</xref>.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Quantification of some chemical compound in EABRP by UPLC-DAD.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Peak</th>
<th align="center">Compound</th>
<th align="center">RT (min)</th>
<th align="center">Concentration (&#xb5;g/ml)</th>
<th align="center">&#xb1; SD</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="left">Daidzein</td>
<td align="char" char=".">11.60</td>
<td align="char" char=".">0.561</td>
<td align="char" char=".">0.070</td>
</tr>
<tr>
<td align="left">2</td>
<td align="left">Liquiritigenin</td>
<td align="char" char=".">12.62</td>
<td align="char" char=".">7.797</td>
<td align="char" char=".">0.628</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">Pinobanksin</td>
<td align="char" char=".">15.66</td>
<td align="char" char=".">0.687</td>
<td align="char" char=".">0.219</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">Isoliquiritigenin</td>
<td align="char" char=".">17.45</td>
<td align="char" char=".">4.537</td>
<td align="char" char=".">0.501</td>
</tr>
<tr>
<td align="left">5</td>
<td align="left">Formononetin</td>
<td align="char" char=".">18.40</td>
<td align="char" char=".">12.154</td>
<td align="char" char=".">0.727</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">Pinocembrin</td>
<td align="char" char=".">22.54</td>
<td align="char" char=".">0.260</td>
<td align="char" char=".">0.040</td>
</tr>
<tr>
<td align="left">7</td>
<td align="left">Biochanin A</td>
<td align="char" char=".">23.52</td>
<td align="char" char=".">0.890</td>
<td align="char" char=".">0.198</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>RT, Retention time (min).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>EABRP UPLC-DAD chromatogram at 280&#xa0;nm. 1 (daidzein), 2 (liquiritigenin), 3 (pinobanksin), 4 (isoliquiritigenin), 5 (formononetin), 6 (pinocembrin) and 7 (biochanin A).</p>
</caption>
<graphic xlink:href="fphar-12-787633-g002.tif"/>
</fig>
<p>In the present work, the total flavonoids content (TFC) was determined by a colorimetric method using AlCl<sub>3</sub> reagent. The TFC were expressed as mg quercetin equivalent (mg&#xa0;QE&#xa0;g<sup>&#x2212;1</sup>) of dried EABRP extract. The EABRP extract contain 54.56&#x20;&#xb1;&#x20;0.25&#xa0;mg&#xa0;QE&#xa0;g<sup>&#x2212;1</sup> of dried EABRP extract <xref ref-type="table" rid="T4">Table&#x20;4</xref>. The radical scavenging capacity (RSC) of EBRP and EABRP were determined by DPPH<sup>&#x2022;</sup> method, the EABRP showed RSC fifteen times bigger than EBRP (<italic>p</italic>&#x20;&#x3c; 0.05) <xref ref-type="table" rid="T4">Table&#x20;4</xref>. The more capacity radical scavenge verified to EABRP was expected because the liquid-liquid extraction leads to it obtain as a more flavonoids enriched extract. The RSC to EABRP not showed statistical difference in comparation with the RSC to the trolox standard (<italic>p</italic>&#x20;&#x3e; 0.05). One of characteristics of a flavonoid enriched extract is precisely its radical scavenging capacity.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Radical scavenge capacity, total flavonoids content, minimal inhibitory concentration and minimal bactericidal concentration of BRP extracts.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Sample</th>
<th align="center">RSC IC<sub>50</sub> (&#x3bc;g ml<sup>&#x2212;1</sup>)</th>
<th align="center">TFC (mg QE&#x2a; g<sup>&#x2212;1</sup> dry extract)</th>
<th align="center">MIC (&#x3bc;g ml<sup>&#x2212;1</sup>)</th>
<th align="center">MBC (&#x3bc;g ml<sup>&#x2212;1</sup>)</th>
</tr>
<tr>
<th align="center">(Mean&#x20;&#xb1; SD)</th>
<th align="center">(Mean&#x20;&#xb1; SD)</th>
<th align="center">
<italic>S. mutans</italic>&#x2a;&#x2a; (Mean&#x20;&#xb1; SD)</th>
<th align="center">
<italic>S. mutans</italic>
<xref ref-type="table-fn" rid="Tfn1">
<sup>&#x2a;&#x2a;</sup>
</xref> (Mean&#x20;&#xb1; SD)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">EABRP</td>
<td align="char" char="plusmn">1.01&#x20;&#xb1; 0.73<sup>a</sup>
</td>
<td align="center">54.56&#x20;&#xb1; 0.25</td>
<td align="center">125&#x20;&#xb1; 0.00</td>
<td align="center">500&#x20;&#xb1; 0.00</td>
</tr>
<tr>
<td align="left">EBRP</td>
<td align="char" char="plusmn">15.63&#x20;&#xb1; 1.22<sup>b</sup>
</td>
<td align="center">-</td>
<td align="center">125&#x20;&#xb1; 0.00</td>
<td align="center">1000&#x20;&#xb1; 0.00</td>
</tr>
<tr>
<td align="left">Trolox</td>
<td align="char" char="plusmn">2.13&#x20;&#xb1; 1.33<sup>a</sup>
</td>
<td align="center">-</td>
<td align="center">-</td>
<td align="center">-</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2a;Quercetin equivalent.</p>
</fn>
<fn>
<p>&#x2a;&#x2a;Antibacterial activity of BRP extracts against <italic>Streptococcus mutans</italic> CCT&#x20;3440.</p>
</fn>
<fn>
<p>-, not determined.</p>
</fn>
<fn>
<p>Different lowercase letters indicate the statistical difference (<italic>p</italic>&#x20;&#x3c; 0.05) between the experimental groups.</p>
</fn>
<fn>
<p>EBRP, Ethanolic Brazilian red propolis; EABRP, Ethyl acetate Brazilian red propolis; RSC, Radical scavenge capacity against DPPH <sup>&#x2022;</sup>; TFC, Total flavonoids content; MIC, minimal inhibitory concentration; MBC, minimal bactericidal concentration.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The antibacterial activity of EBRP and EARP against <italic>Streptococcus mutans</italic> CCT 3440 was determined by broth microdilution assay where the minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC), were determined to each extract. The MIC values to EBRP and EABRP were of 125&#xa0;&#x3bc;g/ml, being both characterized as bacteriostatic extracts at this concentration for this bacterial strain. The EABRP extract showed MBC value of 500&#xa0;&#x3bc;g/ml, being twice more active than EBRP extract that showed MBC value of 1000&#xa0;&#x3bc;g/ml, <xref ref-type="table" rid="T4">Table&#x20;4</xref>.</p>
</sec>
<sec id="s3-2">
<title>Biologic Characterization of Composite Resin Enriched With Brazilian Red Propolis</title>
<p>Brazilian red propolis enriched composite resins were developed by the addiction of EABRP extract at the concentrations of 0.10%, 0.15%, and 0.25% (w/w) in a commercial composite resin to obtaining the formulations RP10, RP15 and RP25, respectively. The biologic characterization of enriched composites was carried out for determination of the antibacterial activity against <italic>Streptococcus mutans</italic> CCT 3440 and the cytotoxicity to 3T3 fibroblasts, respectively.</p>
<p>The antibacterial activity of Brazilian red propolis enriched composite resins was performed by direct contact test and the antibacterial ratio (r %) was determined <xref ref-type="fig" rid="F3">Figure&#x20;3</xref>. The statistical results shows that the antibacterial ratio of RP25 was 90.76&#x20;&#xb1; 6.43 (<italic>p</italic>&#x20;&#x3c; 0.0001) and that negative control (RC) did not exhibit significant antibacterial ratio (<italic>p</italic>&#x20;&#x3d; 0.1865) after 1&#xa0;h of direct contact, both in comparison with cell control. The addition of EABRP to the commercial composite resulted in an enriched composite and with antibacterial activity against <italic>S. mutans</italic> CCT 3440 after 1&#xa0;h of direct contact. The use of methacrylate&#x2019;s monomer hema as solvent for incorporate propolis to commercial composite in the development phase contributed to the antibacterial activity verified to RP25. This fact is confirmed by antibacterial activity exhibit for RS with an antibacterial ratio of 69.23&#x20;&#xb1; 12.16 (<italic>p</italic>&#x20;&#x3d; 0.0006) when compared with cell control. When comparing RP25 and RS with RC, separately, both shows statistical difference in relation of this commercial composite resin (<italic>p</italic>&#x20;&#x3d; 0.0019 and <italic>p</italic>&#x20;&#x3d; 0.0454, respectively) <xref ref-type="table" rid="T5">Table&#x20;5</xref>. Thereby, the null hypothesis was discarded and considered the test hypothesis that the addition of EABRP in hema in commercial composite resin led to obtainment of a EABRP enriched composite resin with antibacterial activity.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Antibacterial ratio (r %) of EABRP enriched composite resin against <italic>S. mutans</italic> after 1h of direct contact test. CC, cell control; RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent. RP25, enriched EABRP composite resin at 0.25% (w/w). &#x2a;&#x2a;&#x2a;: <italic>p</italic>&#x20;&#x3d; <italic>0</italic>.002 &#x2a;&#x2a;&#x2a;&#x2a;: <italic>p</italic>&#x20;&#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fphar-12-787633-g003.tif"/>
</fig>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Antibacterial ratio and cytotoxicity of Brazilian red propolis enriched dental composite.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Sample</th>
<th align="center">r (%)</th>
<th align="center">Cell viability (%) at dose of 3.0&#xa0;cm<sup>2</sup> of dental composite/mL</th>
</tr>
<tr>
<th align="center">(Mean&#x20;&#xb1; SD)</th>
<th align="center">(Mean&#x20;&#xb1; SD)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">CC</td>
<td align="char" char="plusmn">0.00&#x20;&#xb1; 30.76</td>
<td align="char" char="plusmn">100&#x20;&#xb1; 0.20</td>
</tr>
<tr>
<td align="left">RC</td>
<td align="char" char="plusmn">29.23&#x20;&#xb1; 27.41<sup>ns</sup>
</td>
<td align="char" char="plusmn">79.82&#x20;&#xb1; 13.12<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">RS</td>
<td align="char" char="plusmn">63.23&#x20;&#xb1; 12.16&#x2a;&#x2a;&#x2a;</td>
<td align="char" char="plusmn">86.8&#x20;&#xb1; 13.38<xref ref-type="table-fn" rid="Tfn3">
<sup>c</sup>
</xref>
</td>
</tr>
<tr>
<td align="left">RP25</td>
<td align="char" char="plusmn">90.76&#x20;&#xb1; 6.43&#x2a;&#x2a;&#x2a;&#x2a;</td>
<td align="char" char="plusmn">117.05&#x20;&#xb1; 18.84<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
<sup>,</sup> <xref ref-type="table-fn" rid="Tfn2">
<sup>b</sup>
</xref>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Statistically significant difference in comparison with RC group, <italic>p</italic>&#x20;&#x3d; 0.0143.</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>Statistically significant difference in comparison with RS group, <italic>p</italic>&#x20;&#x3d; 0.0293.</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>no statistically significant difference in comparison between RC and RS, <italic>p</italic>&#x20;&#x3d; 0.8981.</p>
</fn>
<fn>
<p>
<sup>ns</sup>: no statistically significant difference in comparison with cell control.</p>
</fn>
<fn>
<p>&#x2a;&#x2a;&#x2a;: statistically significant difference in comparison with cell control, <italic>p</italic>&#x20;&#x3d; 0.0006.</p>
</fn>
<fn>
<p>&#x2a;&#x2a;&#x2a;&#x2a;: statistically significant difference in comparison with cell control, <italic>p</italic>&#x20;&#x3c; 0.0001.</p>
</fn>
<fn>
<p>CC, cell control (Streptococcus mutans CCT 3440); RC, commercial dental composite; RS, commercial dental composite &#x2b; hema solvent; RP25, Ethyl acetate Brazilian red propolis extract enriched dental composite at 0.25% (w/w); r (%), antibacterial&#x20;ratio.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="s3-2-1">
<title>Cytotoxicity</title>
<p>The cytotoxicity of BRP enriched composite resins was determined by MTT assay against fibroblasts 3T3. In this assay were observed the effect of addition of BRP in the commercial composite resins and the effect of composite resins dose on the cytotoxicity. The usual dose of composite resin for this assay was defined as ratio of 3.0&#xa0;cm<sup>2</sup> of composite resin/mL (surface area/volume), conforming ISO 10993-12 (<xref ref-type="bibr" rid="B36">International Organization for Standarization, 2006</xref>). The result shows that the groups RP25, RC and RS no presented cytotoxicity to 3T3 fibroblasts, once that after 24&#xa0;h of exposition to composite resins extracts the cell viability were bigger than 70% <xref ref-type="fig" rid="F4">Figure&#x20;4</xref>. Nevertheless, was observed statistically significant difference on the cell viability between experimental groups when analyzed the addition of BRP to the composite resin (<italic>p</italic>&#x20;&#x3c; 0.0001). The dose effect was not statistically significant (<italic>p</italic>&#x20;&#x3d; 0.0611). Comparing the results for groups RP25, RC and RS at ratio of 3.0&#xa0;cm<sup>2</sup> is possible observed that the cells show bigger viability after exposition to RP25 than after to RC and to RS exposition (<italic>p</italic>&#x20;&#x3c; 0.05), respectively, as shows <xref ref-type="table" rid="T5">Table&#x20;5</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Cytotoxicity of EABRP enriched composite resin against 3T3 fibroblast. Dot line: cell control (100% viability); RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP25, enriched EABRP composite resin at 0.25% (w/w). &#x2a;: <italic>p</italic>&#x20;&#x3c; 0.05 (comparison between RP and RC).</p>
</caption>
<graphic xlink:href="fphar-12-787633-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-3">
<title>Mechanical Characterization</title>
<sec id="s3-3-1">
<title>Three-Point Flexural Strength and Knoop Microhardness</title>
<p>BRP enriched composite resins exhibit flexural strength above of 100&#xa0;MPa, according to the ISO 4049 specifications (minimal FS of 80&#xa0;MPa). Formulations RP10, RP15, RP25 and RS are statistically similar (<italic>p</italic>&#x20;&#x3e; 0.05) and RC shows the biggest FS 125.57 MPa&#x20;&#xb1; 11.49 (<italic>p</italic>&#x20;&#x3c; 0.05) <xref ref-type="fig" rid="F5">Figure&#x20;5A</xref>. KHN for RS, RP10, RP15 and RP25 were 19.4&#x20;&#xb1; 1.5, 18.6&#x20;&#xb1; 1.3, 18.2&#x20;&#xb1; 1.3 and 18.8&#x20;&#xb1; 1.1, respectively <xref ref-type="fig" rid="F5">Figure&#x20;5B</xref>. The KHN for commercial composite resin (RC) was 24.8&#x20;&#xb1; 1.0. The addiction of HEMA, a methacrylate monomer solvent used as diluent in composite resin development was responsible by decrease of the mechanical properties of BRP enriched composite resins compared with RC (<italic>p</italic>&#x20;&#x3c; 0.05) once that promotes the decrease of viscosity in comparation. Decrease of viscosity in composite resins is caused by decreased of filler proportion in the composite.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Mechanical characterization of EABRP enriched composite resin. <bold>(A)</bold>: Flexural strength determination (MPa). Dot line: minimal limit of 80&#xa0;MPa (ISO 4049). <bold>(B)</bold>: Knoop microhardness. RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP10, RP15 and RP25, enriched EABRP composite resins at 0.10, 0.15 and 0.25% (w/w).</p>
</caption>
<graphic xlink:href="fphar-12-787633-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-4">
<title>Physicochemical Characterization</title>
<sec id="s3-4-1">
<title>Post-Cure Depth</title>
<p>Composites enriched with red propolis showed a cure depth compatible with the commercial composites used as a basis in this study, the bulk composites (with increment of &#x2265; 4.0&#x20;&#xb1; 0.1&#xa0;mm), except RP25. The post-cure depth of RP25 and RP15 was 2.74&#x20;&#xb1; 0.06&#xa0;mm and 3.80&#x20;&#xb1; 0.30&#xa0;mm, respectively, both smaller than RC (5.86&#x20;&#xb1; 0.03&#xa0;mm), RS (5.69&#x20;&#xb1; 0.05&#xa0;mm) and RP10 (4.48&#x20;&#xb1; 0.34&#xa0;mm) composites <xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>. The post-cure depth among the enriched composites was inversely proportional to the red propolis concentration: RP10 &#x3e; RP15 &#x3e; RP25. This phenomenon can be explained because the increase of red propolis concentration at composites led to decrease of its translucency, decreasing the capacity of irradiation of the curing light through sample. The Shapiro-Wilk normality test exhibit a non-normal distribution of post-cure depth results; therefore, the Kruskal-Wallis nonparametric test was performed. There was not statistically significant difference between three formulations of enriched composite resins (<italic>p</italic>&#x20;&#x3e; 0.05), but there was statistically significant difference between: RP25 and RC (<italic>p</italic>&#x20;&#x3d; 0.0002); RC and RP15 (<italic>p</italic>&#x20;&#x3d; 0.0171). The statistical analysis demonstrated that there was not significant difference between RC and RP10 (<italic>p</italic>&#x20;&#x3d; 0.2546). In this way, RP10 can be considered a bulk enriched composite&#x20;resin.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Physical-chemical characterization of EABRP enriched composite resins. <bold>(A)</bold>: Depth of cure. <bold>(B)</bold>: Degree of conversion. <bold>(C)</bold>: Water sorption. <bold>(D)</bold>: Water solubility. RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP10, RP15 and RP25, enriched EABRP composite resins at 0.10, 0.15 and 0.25% (w/w).</p>
</caption>
<graphic xlink:href="fphar-12-787633-g006.tif"/>
</fig>
</sec>
<sec id="s3-4-2">
<title>Degree of Conversion</title>
<p>This study analyzed the degree of conversion of BRP enriched composite resins by FTIR spectroscopy in twice moments: immediately after light curing photoactivation and 24&#xa0;h after photoactivation. Was observed that the addition of EARP-HEMA to the commercial composite promoted a significant increase in the DC% of enriched composites when compared to the RC <xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>. When analyzing each moment separately, is possible verify that at first moment RS, RP10, RP15 and RP25 are statistically similar each other (<italic>p</italic>&#x20;&#x3e; 0.05) showing DC% among 76.95&#x20;&#xb1; 2.24% to 79.81&#x20;&#xb1; 0.39% and have bigger DC% than RC with 60.17&#x20;&#xb1; 3.09% (<italic>p</italic>&#x20;&#x3c; 0.0001). At the second moment this result profile remains: RS, RP10, RP15 and RP25 are statistically similar each other (<italic>p</italic>&#x20;&#x3e; 0.05) showing DC% from 80.70&#x20;&#xb1; 4.07% to 83.96&#x20;&#xb1; 2.87% and have bigger DC% than RC with 69.58&#x20;&#xb1; 4.51% (<italic>p &#x3c;</italic> 0.029).</p>
</sec>
<sec id="s3-4-3">
<title>Water Sorption and Water Solubility</title>
<p>The BRP enriched composite resins, RC and RS controls exhibited values conforming ISO 4049 specification for Wsp (&#x2264;40.0&#xa0;&#x3bc;g/mm<sup>3</sup>) <xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>. RS, RP10, RP15 and RP25 were statistically like each other (<italic>p</italic>&#x20;&#x3e; 0.05), but smaller than of RC (<italic>p</italic>&#x20;&#x3c; 0.028). The Wsl for BRP enriched composite resins was conforming ISO 4049 (&#x2264;7.5&#xa0;&#x3bc;g/mm<sup>3</sup>) <xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>. The Shapiro-Wilk test demonstrated that Wsl data have non-normal distribution, therefore was conducted the Kruskal-Wallis test (<italic>p</italic>&#x20;&#x3c; 0.05) for this assay. Was observed that RP25 showed a median of 3.9&#xa0;&#x3bc;g/mm<sup>3</sup>, exhibiting a bigger Wsl than RC with 0.68&#xa0;&#x3bc;g/mm<sup>3</sup> (<italic>p</italic>&#x20;&#x3d; 0.0109). The groups RC, RS, RP10 and RP15 no showed statistically significant difference (<italic>p</italic>&#x20;&#x3e; 0.05) each&#x20;other.</p>
</sec>
<sec id="s3-4-4">
<title>Average Roughness</title>
<p>Topographic images obtained in AFM, representative of the average surface roughness (Ra) of the experimental groups are presented in <xref ref-type="fig" rid="F7">Figure&#x20;7A</xref>. The values of Ra for BRP enriched composite resins are presented in <xref ref-type="fig" rid="F7">Figure&#x20;7B</xref> and show that all groups presented average surface roughness below 21&#xa0;nm. RS, RP10, RP15 and RP25 exhibited small Ra than RC (<italic>p</italic>&#x20;&#x3c; 0.0001), being RC presented the lowest Ra (6.59&#x20;&#xb1; 1.94&#xa0;nm), followed for RP15 (14.48&#x20;&#xb1; 1.63&#xa0;nm). There was no significant difference (<italic>p</italic>&#x20;&#x3e; 0.05) between the Ra values of groups RS (19.24&#x20;&#xb1; 1.87&#xa0;nm), RP10 (20.58&#x20;&#xb1; 3.86&#xa0;nm) and RP25 (20.76&#x20;&#xb1; 2.31&#xa0;nm).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Average roughness (Ra) of EABRP enriched composite resins. <bold>(A)</bold>: Topographic images obtained by AFM for experimental groups. <bold>(B)</bold>: Average roughness values (Ra) for all resins analyzed. RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP10, RP15 and RP25, enriched EABRP composite resins at 0.10, 0.15 and 0.25% (w/w).</p>
</caption>
<graphic xlink:href="fphar-12-787633-g007.tif"/>
</fig>
</sec>
<sec id="s3-4-5">
<title>Thermal Analysis (TGA e DSC)</title>
<p>Was performed the thermal analysis for BRP enriched composite resins for determination of its thermal events of degradation that explain the degree of formation of covalent bonds in the composite polymeric chains. The more resistant to thermal degradation below 600&#xb0;C, the greater the number of covalent bonds existing in the three-dimensional structure of the composite. The TGA, DTG and DSC thermograms are shown in <xref ref-type="fig" rid="F8">Figure&#x20;8</xref>. The thermogravimetric profiles of the studied groups were similar, where all groups presented two events of mass loss, one between 334&#x2013;379&#xb0;C and the other between 448&#x2013;455&#xb0;C. All composite resins formulations analyzed presented thermal resistance between 300&#x2013;350&#xb0;C, since no group had mass loss of up to 5% below these temperatures <xref ref-type="fig" rid="F8">Figure&#x20;8A</xref>. The values of thermogravimetric events can be observed in <xref ref-type="table" rid="T6">Table&#x20;6</xref>, where it is observed that the addition of EARP-HEMA led to increased thermal resistance of composite resins.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Overlapping thermograms of experimental and control resins. <bold>(A)</bold>: Overlapping TGA and DTG thermograms. <bold>(B)</bold>: Overlapping DSC thermograms.</p>
</caption>
<graphic xlink:href="fphar-12-787633-g008.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Thermal resistance, T<sub>0</sub>, T<sub>1</sub>, T<sub>2</sub> and residual mass at 600&#xb0;C of EABRP enriched composite resins.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Group</th>
<th align="center">Thermal resistance (&#xba;C)</th>
<th align="center">T<sub>0</sub> (&#xba;C)</th>
<th align="center">T<sub>1</sub> (&#xba;C)</th>
<th align="center">T<sub>2</sub> (&#xba;C)</th>
<th align="center">Residual mass at 600&#xb0;C(%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">RC</td>
<td align="center">325</td>
<td align="center">216</td>
<td align="center">334</td>
<td align="center">448.5</td>
<td align="char" char=".">65.05</td>
</tr>
<tr>
<td align="left">RS</td>
<td align="center">340</td>
<td align="center">216</td>
<td align="center">373</td>
<td align="center">452</td>
<td align="char" char=".">58.02</td>
</tr>
<tr>
<td align="left">RP10</td>
<td align="center">339</td>
<td align="center">230</td>
<td align="center">355</td>
<td align="center">449</td>
<td align="char" char=".">58.35</td>
</tr>
<tr>
<td align="left">RP15</td>
<td align="center">349</td>
<td align="center">232</td>
<td align="center">379.8</td>
<td align="center">455</td>
<td align="char" char=".">58.18</td>
</tr>
<tr>
<td align="left">RP25</td>
<td align="center">349</td>
<td align="center">233</td>
<td align="center">379</td>
<td align="center">453</td>
<td align="char" char=".">58.73</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Thermal resistance, temperature where there is a loss of 5% of the initial mass of the dental composite; T<sub>0</sub>, temperature of onset of thermal degradation; T<sub>1</sub>, primary thermal degradation temperature; T<sub>2</sub>, secondary thermal degradation temperature; RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP10, RP15 and RP25, enriched EABRP composite resins at 0.10, 0.15 and 0.25% (w/w).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>All samples presented similar DSC profile between each other, with two events of thermal decomposition of the polymer matrix in 368&#xb0;C and 407&#xb0;C, and the beginning of thermal degradation of the composite stars at &#x223c; 560&#xb0;C <xref ref-type="fig" rid="F8">Figure&#x20;8B</xref>. It was observed that the addition of EARP-HEMA led to a increase in the heat variation involved in the thermal decomposition of the polymer matrix of enriched composite resins. The values of DSC events can be observed in <xref ref-type="table" rid="T7">Table&#x20;7</xref>.</p>
<table-wrap id="T7" position="float">
<label>TABLE 7</label>
<caption>
<p>Thermal decomposition events of EABRP enriched composite resins.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Group</th>
<th align="center">T<sub>1</sub>(&#xba;C)/heat (J/g)</th>
<th align="center">T<sub>2</sub>(&#xba;C)/heat (J/g)</th>
<th align="center">T<sub>3</sub>(&#xba;C)/heat (J/g)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">RC</td>
<td align="char" char="/">368.24/8.82</td>
<td align="char" char="/">422.4/25.01</td>
<td align="char" char="/">563.66/9.51</td>
</tr>
<tr>
<td align="left">RS</td>
<td align="char" char="/">378.49/13.15</td>
<td align="char" char="/">407.43/84.48</td>
<td align="char" char="/">583.83/152.61</td>
</tr>
<tr>
<td align="left">RP10</td>
<td align="char" char="/">368.86/9.40</td>
<td align="char" char="/">404.65/71.53</td>
<td align="char" char="/">565.90/216.52</td>
</tr>
<tr>
<td align="left">RP15</td>
<td align="char" char="/">375.14/18.70</td>
<td align="char" char="/">402.17/216.87</td>
<td align="char" char="/">561.69/276.95</td>
</tr>
<tr>
<td align="left">RP25</td>
<td align="char" char="/">371.85/30.98</td>
<td align="char" char="/">405.80/369.55</td>
<td align="char" char="/">550.52/206.26</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>T<sub>1</sub>, First thermal decomposition event; T<sub>2</sub>, second thermal decomposition event; T<sub>3</sub>, Start of thermal degradation of the fillers; RC, commercial resin; RS, commercial resin &#x2b; HEMA solvent; RP10, RP15 and RP25, enriched EABRP composite resins at 0.10, 0.15 and 0.25% (w/w).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The Ethyl acetate Brazilian red propolis extract (EABRP) was chose for enriched composite resin development because its antibacterial activity against <italic>Streptococcus mutans</italic> CCT 3440. Main idea in development of BRP enriched composite resin was the obtain of a antibacterial composite resin against <italic>Streptococcus mutans</italic>, the primary etiologic agent of caries (<xref ref-type="bibr" rid="B39">Koo et&#x20;al., 2003</xref>). Phenolic acids, flavonoids, chalcones, triterpenes and prenylated benzophenones detected by LC-ESI-Orbitrap-FTMS in BRP extracts are characteristic for Brazilian red propolis collected in the northeast Brazil region (<xref ref-type="bibr" rid="B31">Frozzada et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B47">L&#xf3;pez et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B21">de Mendon&#xe7;a et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B30">Freires et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B68">Rufatto et&#x20;al., 2018</xref>). The flavonoids formononetin, biochanin A, daidzein, liquiritigenin and the chalcone isoliquiritigenin, quantify on this study, are some of markers describes for BRP (<xref ref-type="bibr" rid="B4">Andrade et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B63">Picolotto et&#x20;al., 2019</xref>). The total flavonoid content for EABRP observed in this work is bigger than ethanol BRP extract describes in another work (31.48&#xa0;mg&#xa0;QE&#xa0;g<sup>&#x2212;1</sup>) because the liquid-liquid extraction carried out concentrated the flavonoids in the acetate phase (<xref ref-type="bibr" rid="B4">Andrade et&#x20;al., 2017</xref>).</p>
<p>The antibacterial results observed for EABRP against <italic>S. mutans</italic> was compatible with results in another studies where ethanol extract of BRP was tested against <italic>S. mutans</italic> UA159 and exhibited MIC and MBC values of 200.0&#xa0;&#x3bc;g/ml for both assay (<xref ref-type="bibr" rid="B11">Bueno-Silva et&#x20;al., 2013</xref>). In another study chloroform extract of BRP exhibited MIC and MBC against <italic>S mutans</italic> of 125 and 500&#xa0;&#x3bc;g/ml, respectively (<xref ref-type="bibr" rid="B55">Oldoni et&#x20;al., 2011</xref>). In a study, the antibacterial activity of eight ethanolic Brazilian propolis extracts from 3 types (red, green, and brown) was analyzed against <italic>Enterococcus</italic> sp. ATCC 2912, <italic>Staphylococcus aureus</italic> ATCC 25923 and <italic>Klebsiella</italic> sp. ATCC 1706/700603, and red propolis showed the highest antibacterial activity against this bacteria with MIC values of 31.3, 62.5, and 31.3&#xa0;&#x3bc;g/ml, respectively (<xref ref-type="bibr" rid="B17">Dantas Silva et&#x20;al., 2017</xref>). These variations in antibacterial results for Brazilian red propolis from the same origin can be explained by seasonality. It is known that the antibacterial activity of propolis may vary depending on seasonality because the presence and concentration of its markers are related with the season, which in turn influences the production of secondary metabolites by the botanical origin of propolis (<xref ref-type="bibr" rid="B66">Regueiro et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B24">do Nascimento et&#x20;al., 2019</xref>).</p>
<p>The use of propolis on technological development in dentistry and oral health has been frequent because it is a nontoxic raw material, with traditional use in natural medicine and that shows some known pharmacological activities as antimicrobial, anti-inflammatory and wound healing (<xref ref-type="bibr" rid="B40">Koo et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B30">Freires et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B56">Oliveirados et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B19">de Carvalho Furtado et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B9">Bezerra et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B16">da silva Barboza et&#x20;al., 2021</xref>). It has been reported in scientific literature the use of propolis on development of varnish (<xref ref-type="bibr" rid="B20">De Luca et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B53">Neto et&#x20;al., 2020</xref>), toothpaste (<xref ref-type="bibr" rid="B80">Wiatrak et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B61">Peycheva et&#x20;al., 2019</xref>), total-etching adhesive system (<xref ref-type="bibr" rid="B65">Porto et&#x20;al., 2021</xref>), cavity cleaning agent (<xref ref-type="bibr" rid="B13">Celerino de Moraes Porto et&#x20;al., 2018</xref>) and endodontic irrigant (<xref ref-type="bibr" rid="B59">Parolia et&#x20;al., 2021</xref>). The use of propolis was not found in the development of composite resins in scientific literature and in technological literature.</p>
<p>The Brazilian red propolis enriched composite resin developed in this study showed antibacterial activity against <italic>S. mutans</italic> CCT 3440 after 1&#xa0;h of direct contact and biocompatibility with 3T3 fibroblasts. Direct contact test has been used for determination of antibacterial and antifungal activity of enriched dental materials (<xref ref-type="bibr" rid="B75">Tavassoli Hojati et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B84">Zhang et&#x20;al., 2017</xref>). The antibacterial activity of Brazilian red propolis enriched composite resins is a result of synergism of several markers present in BRP (<xref ref-type="bibr" rid="B82">Xie et&#x20;al., 2014</xref>). Some examples of antimicrobial action mechanism for flavonoids presents in BRP are listed in the scientific literature as inhibition of nuclei acids synthesis (quercetin, chrysin, kaempferol), inhibition of quorum sensing (naringenin, kaempferol) and membrane disruption (naringenin, catechin) (<xref ref-type="bibr" rid="B74">Silva et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B79">Wang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B10">Biharee et&#x20;al., 2020</xref>).</p>
<p>In a study, the isolated flavanone naringenin had a MIC value of 500&#xa0;&#x3bc;g/ml (1.84&#xa0;mM) against <italic>S. aureus</italic>, a Gram positive bacteria (<xref ref-type="bibr" rid="B79">Wang et&#x20;al., 2018</xref>). The same study showed that at 400&#xa0;&#x3bc;g/ml (1.47&#xa0;mM), naringenin down-regulated expression levels of <italic>fabD, fabF, fabG, fabH and fabI</italic>, genes associated with biosynthesis of fatty acid from cell membrane of <italic>S. aureus</italic>. The authors report that this down-regulating leading to modification of cell membrane fatty acid content, increasing the membrane fluidity and resulting in decrease of bacterial cell viability (<xref ref-type="bibr" rid="B79">Wang et&#x20;al., 2018</xref>). Naringenin and other flavanones as liquiritigenin, 6-methoxyflavanone, 6-hydroxynaringenin, pinostrobin and pinocembrin was identified in EABRP used in this study. In the scientific literature, the structure activity relationship of flavanones was evaluated for the against Gram positive and was observed that two hydroxyl groups in the ring A at the C-5 and C-7 positions and none hydroxyl group in the ring B is a major contributing factor towards antibacterial activity, as pinocembrin (<xref ref-type="bibr" rid="B25">Echeverr et&#x20;al., 2017</xref>). Studies of Chalcones structure activity relationship highlight the importance of hydroxyl group at C2&#x2032;, C4&#x2032; and C4 for antibacterial activity (<xref ref-type="bibr" rid="B6">&#xc1;vila et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B82">Xie et&#x20;al., 2014</xref>). The chalcone isoliquiritigenin, quantified in EABRP at concentration of 4.53&#xa0;&#x3bc;g/ml, has this chemical arrangement.</p>
<p>New dental composites have been developed from the incorporation of antibacterial agents (<xref ref-type="bibr" rid="B8">Beyth et&#x20;al., 2014</xref>). These agents can be inorganic particles, modified monomers or additives incorporated into both the polymer matrix and the charge particles, such as zinc oxide nanoparticles (<xref ref-type="bibr" rid="B7">Beyth et&#x20;al., 2013</xref>, <xref ref-type="bibr" rid="B8">2014</xref>; <xref ref-type="bibr" rid="B69">R&#xfc;ttermann et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B75">Tavassoli Hojati et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B35">Inagaki et&#x20;al., 2016</xref>), silica nanoparticles functionalized with amphotericin B (<xref ref-type="bibr" rid="B45">Lino et&#x20;al., 2013</xref>), silver nanoparticles (<xref ref-type="bibr" rid="B26">Fan et&#x20;al., 2011</xref>), modified monomers containing quaternary ammonium (<xref ref-type="bibr" rid="B34">Imazato et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B49">Makvandi et&#x20;al., 2016</xref>, <xref ref-type="bibr" rid="B48">2018</xref>) and antibacterial agents immobilized in composite (<xref ref-type="bibr" rid="B52">Namba et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B50">Mankovskaia et&#x20;al., 2013</xref>). The concept of modified surfaces is reported in the scientific literature mainly for the purpose of developing antimicrobial and bioequivalent health materials (<xref ref-type="bibr" rid="B12">Busscher et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B74">Silva et&#x20;al., 2016</xref>). Thus, surface-modified materials can be classified in five different ways: nonadhesive, tissue-integrating, contact-killing, antimicrobial-releasing coatings and multifunction coatings (<xref ref-type="bibr" rid="B12">Busscher et&#x20;al., 2012</xref>).</p>
<p>The evidence that composite resins normally release some free monomers both in the oral cavity and in the dental pulp and that this release can cause toxicity is already well established in the literature (<xref ref-type="bibr" rid="B71">Schweikl et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B54">Nocca et&#x20;al., 2011</xref>). In addition, there is a positive correlation between the toxicity of these composites and their monomers with oxidative stress that they can cause to normal cells in the oral cavity (<xref ref-type="bibr" rid="B41">Krifka et&#x20;al., 2012</xref>, <xref ref-type="bibr" rid="B42">2013</xref>; <xref ref-type="bibr" rid="B60">Perduns et&#x20;al., 2019</xref>). The enzyme glutathione peroxidase (GPx1) it is present in both cell cytoplasm and mitochondrial matrix and acts reducing H<sub>2</sub>O<sub>2</sub> to H<sub>2</sub>O when reduced glutathione (GSH), an tripeptide and endogenous antioxidant, levels are high (<xref ref-type="bibr" rid="B41">Krifka et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B73">Sies et&#x20;al., 2017</xref>). The mechanism of oxidative stress in oral cell caused by methacrylate monomers involves the decrease in cellular levels of GSH due to the formation of the GSH-methacrylate monomer adduct that leads to glutathione peroxidase (GPx1) inhibition with a consequent increase in H<sub>2</sub>O<sub>2</sub> levels in cell. Accumulation of H<sub>2</sub>O<sub>2</sub> into oral cells leads to oxidative stress, in this process started by exposure to methacrylate monomers (<xref ref-type="bibr" rid="B41">Krifka et&#x20;al., 2012</xref>). To reduce this GSH-methacrylate monomer adduct formation, studies have developed composite resins containing antioxidants species as ascorbic acid and N-acetylcysteine (<xref ref-type="bibr" rid="B83">Yang et&#x20;al., 2019</xref>). The Brazilian red propolis DPPH radical scavenging capacity suggest a possible explanation for the statistical difference found between enriched and commercial composite resin in the cytotoxicity assay in this study, when the phenolic compounds of BRP can be inhibition the GSH-methacrylate monomer. More studies are necessary to confirm this supposition.</p>
<p>The enriched Brazilian red propolis composite resin exhibited flexural resistance higher than 100&#xa0;MPa, exceeding the 80&#xa0;MPa values indicated for polymer-based restorative materials (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2000</xref>), In the mechanical tests of flexural resistance and Knoop microhardness, the insertion of the HEMA diluent was determinant for the reduction of the properties observed between the RC group and the other groups. The DC% of 60% for filtek bulk fill flow composite resin is according with scientific literature data (<xref ref-type="bibr" rid="B64">Pongprueksa et&#x20;al., 2015</xref>). The increase of DG% exhibited by modified composite resin (RS and RPs) was provided by EABRP-HEMA incorporation. This fact is confirmed by thermal analysis data, where RP15 and RP25 showed increase in thermal resistance when compared to RC. This increase on thermal resistance happens by EABRP-HEMA addition that promoted formation of cross-links in the 3D structure of the polymer (<xref ref-type="bibr" rid="B1">Achilias et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B77">Vouvoudi et&#x20;al., 2015</xref>). The main monomer at the RPs composition, the urethane dimethacrylate, is able to form hydrogen bonds with the phenolic compounds present in the red propolis, making the polymeric network more cross-linked and consequently more thermal resistant (<xref ref-type="bibr" rid="B2">Achilias et&#x20;al., 2008</xref>). The bigger DC% for RP25 in comparation with DC% for RC mean a smaller amount of free monomers in enriched composites that contributes for the smaller cytotoxicity exhibited by&#x20;RP25.</p>
<p>Sorption has an important negative correction with the amount of composite filler. When the percentage filler increases, the polymer matrix decreases and consequently decreases water sorption, which is a phenomenon associated mainly with the polymer matrix (<xref ref-type="bibr" rid="B3">Alshali et&#x20;al., 2015</xref>). In this study, all BRP enriched resins showed a significant increase in water sorption. Even so, the values were lower than the maximum recommended value of 40&#xa0;&#x3bc;g/mm<sup>3</sup> according to the ISO standard for restorative resins (<xref ref-type="bibr" rid="B37">International Organization for Standarization, 2000</xref>). Finally, the roughness of composite resins can be classify as mild (Ra &#x2264; 25&#xa0;nm), moderately rough (25&#xa0;mn &#x3e; Ra &#x2264; 150&#xa0;nm) and rough (&#x3e;150&#xa0;nm) (<xref ref-type="bibr" rid="B51">Mei et&#x20;al., 2011</xref>). According to this classification, all composites tested RC, RS, RP10, RP15 and RP25 are considered as mildly roughness.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Up to our knowledge, this is a first study which describes the use of propolis on composite resins development. The phytochemical profile of Brazilian red propolis was characterized and used BRP extract showed up bacteriostatic and bactericide against <italic>Streptococcus mutans</italic>. A BRP enriched composite resin (RP25) was obtained by commercial composite resin modification. RP25 exhibited antibacterial activity against <italic>S. mutans</italic> by direct contact test and no showed cytotoxicity against 3T3 fibroblasts. The RP25 exhibited compatible mechanical and physical-chemical properties to the indicate for composite resins. Finally, more one application of propolis on development of materials for healthcare was carried, obtaining a BRP enriched composite resin characterized as an unprecedented, biocompatible, and antibacterial dental material.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the corresponding author on request.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>Conceived and designed the experiments: JO, IP, TN, and JT. Conducted the experiment(s): JO, IP, TC, FA, AS, and RL. Analyzed and interpreted the data: JO, DS, IP, RV, JF, EB, SS, RK, TN, and JT. Contributed reagents, materials, analysis tools or data: IP, RV, JF, EB, SS, RK, TN, and JT. Gathered the literature data: JO, IP, TC, DS, FA, IL, TN, and JT. Wrote the paper: JO, IP, TC, DS, FA, AS, IL, RL, RV, JF, EB, SS, RK, TN, and JT. All authors reviewed the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the Brazilian National Council for Scientific and Technological Development (CNPq), project 870220/2000-4, process 140765/2016-6. The funding received was from a doctoral grant.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>The authors acknowledge the CNPq (Brazilian National Council for Scientific and Technological Development) for funding the project. The authors would like to acknowledge FAPEAL (Foundation for Sponsoring Research in the State of Alagoas) and CAPES (The Brazilian Coordination for the Personal Improvement of Superior Education) for supporting the groups infrastructure.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.787633/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2021.787633/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image2.pdf" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Image1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achilias</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Karabela</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Sideridou</surname>
<given-names>I. D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Thermal Degradation and Isoconversional Kinetic Analysis of Light-Cured Dimethacrylate Copolymers</article-title>. <source>J.&#x20;Therm. Anal. Calorim.</source> <volume>99</volume>, <fpage>917</fpage>&#x2013;<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1007/s10973-009-0526-1</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Achilias</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Karabela</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Sideridou</surname>
<given-names>I. D.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Thermal Degradation of Light-Cured Dimethacrylate Resins</article-title>. <source>Thermochim. Acta.</source> <volume>472</volume>, <fpage>74</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.tca.2008.02.004</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alshali</surname>
<given-names>R. Z.</given-names>
</name>
<name>
<surname>Salim</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Satterthwaite</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Silikas</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Post-irradiation Hardness Development, Chemical Softening, and thermal Stability of Bulk-Fill and Conventional Resin-Composites</article-title>. <source>J.&#x20;Dent.</source> <volume>43</volume>, <fpage>209</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdent.2014.12.004</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andrade</surname>
<given-names>J.&#x20;K. S.</given-names>
</name>
<name>
<surname>Denadai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Oliveira</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Narain</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Evaluation of Bioactive Compounds Potential and Antioxidant Activity of Brown, green and Red Propolis from Brazilian Northeast Region</article-title>. <source>Food Res. Int.</source> <volume>101</volume>, <fpage>129</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2017.08.066</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arafa</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Ghalwash</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>El-Kersh</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Elmazar</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Propolis-based Niosomes as Oromuco-Adhesive Films: A Randomized Clinical Trial of a Therapeutic Drug Delivery Platform for the Treatment of Oral Recurrent Aphthous Ulcers</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>18056</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-37157-7</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc1;vila</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Sm&#xe2;nia</surname>
<given-names>E. F.</given-names>
</name>
<name>
<surname>Monache</surname>
<given-names>F. D.</given-names>
</name>
<name>
<surname>Sm&#xe2;nia</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Structure-activity Relationship of Antibacterial Chalcones</article-title>. <source>Bioorg. Med. Chem.</source> <volume>16</volume>, <fpage>9790</fpage>&#x2013;<lpage>9794</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2008.09.064</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beyth</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Farah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Domb</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>E. I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Antibacterial Dental Resin Composites</article-title>. <source>Reactive Funct. Polym.</source> <volume>75</volume>, <fpage>81</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.reactfunctpolym.2013.11.011</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beyth</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Farah</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Domb</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>E. I.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Reactive &#x26; Functional Polymers Antibacterial Dental Resin Composites</article-title>. <source>React. Funct. Polym.</source> <volume>75</volume>, <fpage>81</fpage>&#x2013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.reactfunctpolym.2013.11.011</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bezerra</surname>
<given-names>C. R. F.</given-names>
</name>
<name>
<surname>Assun&#xe7;&#xe3;o Borges</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>R. d. N. S.</given-names>
</name>
<name>
<surname>Teles</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Pimentel Rodrigues</surname>
<given-names>I. V.</given-names>
</name>
<name>
<surname>Da Silva</surname>
<given-names>M. A. C. N.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Highly Efficient Antibiofilm and Antifungal Activity of green Propolis against Candida Species in Dentistry Materials</article-title>. <source>PLoS One</source> <volume>15</volume>, <fpage>e0228828</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0228828</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biharee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jaitak</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antimicrobial Flavonoids as a Potential Substitute for Overcoming Antimicrobial Resistance</article-title>. <source>Fitoterapia</source> <volume>146</volume>, <fpage>104720</fpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2020.104720</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bueno-Silva</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Alencar</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ikegaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Napimoga</surname>
<given-names>M. H.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Anti-inflammatory and Antimicrobial Evaluation of Neovestitol and Vestitol Isolated from Brazilian Red Propolis</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>61</volume>, <fpage>4546</fpage>&#x2013;<lpage>4550</lpage>. <pub-id pub-id-type="doi">10.1021/jf305468f</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busscher</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Van Der Mei</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Subbiahdoss</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jutte</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Van Den Dungen</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Zaat</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Biomaterial-associated Infection: Locating the Finish Line in the Race for the Surface</article-title>. <source>Sci. Transl. Med.</source> <volume>4</volume>, <fpage>153rv10</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.3004528</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celerino de Moraes Porto</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Chaves Cardoso de Almeida</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Vasconcelos Calheiros de Oliveira Costa</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sampaio Donato</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Moreira Nunes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gomes do Nascimento</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Mechanical and Aesthetics Compatibility of Brazilian Red Propolis Micellar Nanocomposite as a Cavity Cleaning Agent</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>18</volume>, <fpage>219</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-018-2281-y</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="book">
<collab>CLSI</collab> (<year>2012</year>). <source>Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically ;Approved Standard</source>. <edition>Ninth Edition</edition>. <publisher-loc>Wayne (Pennsylvania)</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>. </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corr&#xea;a</surname>
<given-names>F. R.</given-names>
</name>
<name>
<surname>Schanuel</surname>
<given-names>F. S.</given-names>
</name>
<name>
<surname>Moura-Nunes</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Monte-Alto-Costa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Daleprane</surname>
<given-names>J.&#x20;B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Brazilian Red Propolis Improves Cutaneous Wound Healing Suppressing Inflammation-Associated Transcription Factor NF&#x3ba;B</article-title>. <source>Biomed. Pharmacother.</source> <volume>86</volume>, <fpage>162</fpage>&#x2013;<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2016.12.018</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva Barboza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aitken-Saavedra</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>F&#xe1;bio Aranha</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Are Propolis Extracts Potential Pharmacological Agents in Human Oral Health? - A Scoping Review and Technology Prospecting</article-title>. <source>J.&#x20;Ethnopharmacology</source> <volume>271</volume>, <fpage>113846</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.113846</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dantas Silva</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Barreto</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>Amaral</surname>
<given-names>R. G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Antioxidant, Antimicrobial, Antiparasitic, and Cytotoxic Properties of Various Brazilian Propolis Extracts</article-title>. <source>PLoS One</source> <volume>12</volume>, <fpage>e0172585</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0172585</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daugsch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moraes</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Fort</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Brazilian Red Propolis-Cchemical Composition and Botanical Origin</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>5</volume>, <fpage>435</fpage>&#x2013;<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1093/ecam/nem057</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Carvalho Furtado</surname>
<given-names>J.&#x20;H.</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Rocha Valadas</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Mendon&#xe7;a</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>de Oliveira Filho</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Gadelha</surname>
<given-names>L. M. U.</given-names>
</name>
<name>
<surname>de Mello Fiallos</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Propolis and its Dental Applications: A Technological Prospection</article-title>. <source>Biot</source> <volume>12</volume>, <fpage>288</fpage>&#x2013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.2174/2211550107666180815114855</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Luca</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Franca</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Macedo</surname>
<given-names>F. A. F. F.</given-names>
</name>
<name>
<surname>Grenho</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cortes</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Faraco</surname>
<given-names>A. A. G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Propolis Varnish: Antimicrobial Properties against Cariogenic Bacteria, Cytotoxicity, and Sustained-Release Profile</article-title>. <source>Biomed. Res. Int.</source> <volume>2014</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1155/2014/348647</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Mendon&#xe7;a</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Porto</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>do Nascimento</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Oliveirados</surname>
<given-names>J.&#x20;M. S.</given-names>
</name>
<name>
<surname>Arrudados</surname>
<given-names>R. E. S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Brazilian Red Propolis: Phytochemical Screening, Antioxidant Activity and Effect against Cancer Cells</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>15</volume>, <fpage>357</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-015-0888-9</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dias</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Bernardi</surname>
<given-names>M. I. B.</given-names>
</name>
<name>
<surname>Bauab</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Hernandes</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>de Souza Rastelli</surname>
<given-names>A. N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Titanium Dioxide and Modified Titanium Dioxide by Silver Nanoparticles as an Anti Biofilm Filler Content for Composite Resins</article-title>. <source>Dent. Mater.</source> <volume>35</volume>, <fpage>e36</fpage>&#x2013;<lpage>e46</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2018.11.002</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>do Nascimento</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Azevedo</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>da Rocha</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>de Moraes Porto</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Lima E Moura</surname>
<given-names>T. F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Polymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity</article-title>. <source>Nanoscale Res. Lett.</source> <volume>11</volume>, <fpage>301</fpage>. <pub-id pub-id-type="doi">10.1186/s11671-016-1517-3</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>do Nascimento</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Dos Santos Arruda</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>da Cruz Almeida</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Dos Santos Oliveirados</surname>
<given-names>J.&#x20;M. S.</given-names>
</name>
<name>
<surname>Bas&#xed;lio-J&#xfa;nior</surname>
<given-names>I. D.</given-names>
</name>
<name>
<surname>Celerino de Moraes Porto</surname>
<given-names>I. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Comprehensive Multivariate Correlations between Climatic Effect, Metabolite-Profile, Antioxidant Capacity and Antibacterial Activity of Brazilian Red Propolis Metabolites during Seasonal Study</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>18293</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-54591-3</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Echeverr&#xed;a</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Opazo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mendoza</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Urz&#xfa;a</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilkens</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Structure-Activity and Lipophilicity Relationships of Selected Antibacterial Natural Flavones and Flavanones of Chilean Flora</article-title>. <source>Molecules</source> <volume>22</volume>, <fpage>608</fpage>. <pub-id pub-id-type="doi">10.3390/molecules22040608</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rawls</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Norling</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Cardenas</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Whang</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Development of an Antimicrobial Resin-Aa Pilot Study</article-title>. <source>Dent. Mater.</source> <volume>27</volume>, <fpage>322</fpage>&#x2013;<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2010.11.008</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferracane</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Resin Composite-Sstate of the Art</article-title>. <source>Dent. Mater.</source> <volume>27</volume>, <fpage>29</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2010.10.020</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Floyd</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Dickens</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Network Structure of Bis-GMA- and UDMA-Based Resin Systems</article-title>. <source>Dent. Mater.</source> <volume>22</volume>, <fpage>1143</fpage>&#x2013;<lpage>1149</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2005.10.009</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franchin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Col&#xf3;n</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Da Cunha</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Castanheira</surname>
<given-names>F. V.</given-names>
</name>
<name>
<surname>Saraiva</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Bueno-Silva</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Neovestitol, an Isoflavonoid Isolated from Brazilian Red Propolis, Reduces Acute and Chronic Inflammation: Involvement of Nitric Oxide and IL-6</article-title>. <source>Sci. Rep.</source> <volume>6</volume>, <fpage>36401</fpage>&#x2013;<lpage>36412</lpage>. <pub-id pub-id-type="doi">10.1038/srep36401</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freires</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>de Alencar</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Rosalen</surname>
<given-names>P. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>A Pharmacological Perspective on the Use of Brazilian Red Propolis and its Isolated Compounds against Human Diseases</article-title>. <source>Eur. J.&#x20;Med. Chem.</source> <volume>110</volume>, <fpage>267</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.01.033</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frozzada</surname>
<given-names>C. O. S.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Gambato</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Salvador</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Chemical Characterization, Antioxidant and Cytotoxic Activities of Brazilian Red Propolis</article-title>. <source>Food Chem. Toxicol.</source> <volume>52</volume>, <fpage>137</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2012.11.013</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Serrano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Pintor</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sanz</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Short-term Efficacy of a Gel Containing Propolis Extract, Nanovitamin C and Nanovitamin E on Peri-Implant Mucositis: A Double-Blind, Randomized, Clinical Trial</article-title>. <source>J.&#x20;Periodont Res.</source> <volume>56</volume>, <fpage>897</fpage>&#x2013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1111/jre.12886</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stansbury</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Braga</surname>
<given-names>R. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Influence of BisGMA, TEGDMA, and BisEMA Contents on Viscosity, Conversion, and Flexural Strength of Experimental Resins and Composites</article-title>. <source>Eur. J.&#x20;Oral Sci.</source> <volume>117</volume>, <fpage>442</fpage>&#x2013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0722.2009.00636.x</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imazato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ebi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kaneko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ebisu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R. R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Antibacterial Activity of Bactericide-Immobilized Filler for Resin-Based Restoratives</article-title>. <source>Biomaterials</source> <volume>24</volume>, <fpage>3605</fpage>&#x2013;<lpage>3609</lpage>. <pub-id pub-id-type="doi">10.1016/s0142-9612(03)00217-5</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inagaki</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>Alonso</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Ara&#xfa;jo</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>de Souza-Junior</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Anibal</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>H&#xf6;fling</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Effect of Monomer Blend and Chlorhexidine-Adding on Physical, Mechanical and Biological Properties of Experimental Infiltrants</article-title>. <source>Dent. Mater.</source> <volume>32</volume>, <fpage>e307</fpage>&#x2013;<lpage>e313</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2016.09.028</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="book">
<collab>International Organization for Standarization</collab> (<year>2006</year>). <source>I</source>
<source>nternational Organization for Standarization ISO 10993-12 Biological Evaluation of Medical Devices &#x2014;&#x20;Part 12: Sample Preparation and Reference Materials</source>. <publisher-loc>Brussels</publisher-loc>: <publisher-name>European Committee For Standardization</publisher-name>. </citation>
</ref>
<ref id="B37">
<citation citation-type="book">
<collab>International Organization for Standarization</collab> (<year>2000</year>). <source>ISO 4049:2000 Dentistry Polymer Based Restorative Materials</source>. <publisher-loc>Switzerland</publisher-loc>: <publisher-name>International Organization</publisher-name>. </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacob</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parolia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pau</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Davamani Amalraj</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The Effects of Malaysian Propolis and Brazilian Red Propolis on Connective Tissue Fibroblasts in the Wound Healing Process</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>15</volume>, <fpage>294</fpage>. <pub-id pub-id-type="doi">10.1186/s12906-015-0814-1</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hayacibara</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Schobel</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Cury</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Rosalen</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. K.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Inhibition of Streptococcus Mutans Biofilm Accumulation and Polysaccharide Production by Apigenin and Tt-Farnesol</article-title>. <source>J.&#x20;Antimicrob. Chemother.</source> <volume>52</volume>, <fpage>782</fpage>&#x2013;<lpage>789</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkg449</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rosalen</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Cury</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Bowen</surname>
<given-names>W. H.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Effects of Compounds Found in Propolis on Streptococcus Mutans Growth and on Glucosyltransferase Activity</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>46</volume>, <fpage>1302</fpage>&#x2013;<lpage>1309</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.46.5.130210.1128/aac.46.5.1302-1309.2002</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krifka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Spagnuolo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jewett</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schmalz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schweikl</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The Influence of Glutathione on Redox Regulation by Antioxidant Proteins and Apoptosis in Macrophages Exposed to 2-hydroxyethyl Methacrylate (HEMA)</article-title>. <source>Biomaterials</source> <volume>33</volume>, <fpage>5177</fpage>&#x2013;<lpage>5186</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.04.013</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krifka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spagnuolo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmalz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schweikl</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>A Review of Adaptive Mechanisms in Cell Responses towards Oxidative Stress Caused by Dental Resin Monomers</article-title>. <source>Biomaterials</source> <volume>34</volume>, <fpage>4555</fpage>&#x2013;<lpage>4563</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.03.019</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H. H. K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The Anti-caries Effects of Dental Adhesive Resin Influenced by the Position of Functional Groups in Quaternary Ammonium Monomers</article-title>. <source>Dent. Mater.</source> <volume>34</volume>, <fpage>400</fpage>&#x2013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2017.11.021</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lima Cavendish</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>de Souza Santos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Belo Neto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Oliveira Paix&#xe3;o</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Val&#xe9;ria Oliveira</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Divino de Araujo</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Antinociceptive and Anti-inflammatory Effects of Brazilian Red Propolis Extract and Formononetin in Rodents</article-title>. <source>J.&#x20;Ethnopharmacol.</source> <volume>173</volume>, <fpage>127</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2015.07.022</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lino</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Paulo</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Vale</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Vaz</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>L. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Antifungal Activity of Dental Resins Containing Amphotericin B-Conjugated Nanoparticles</article-title>. <source>Dent. Mater.</source> <volume>29</volume>, <fpage>e252</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2013.07.023</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Effect of Hydroxyapatite Whisker Surface Graft Polymerization on Water Sorption, Solubility and Bioactivity of the Dental Resin Composite</article-title>. <source>Mater. Sci. Eng. C Mater. Biol. Appl.</source> <volume>53</volume>, <fpage>150</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2015.04.043</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Eberlin</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Sawaya</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Phytochemical Markers of Different Types of Red Propolis</article-title>. <source>Food Chem.</source> <volume>146</volume>, <fpage>174</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.09.063</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makvandi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jamaledin</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jabbari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nikfarjam</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Borzacchiello</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antibacterial Quaternary Ammonium Compounds in Dental Materials: A Systematic Review</article-title>. <source>Dent. Mater.</source> <volume>34</volume>, <fpage>851</fpage>&#x2013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2018.03.014</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makvandi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ghaemy</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mohseni</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Synthesis and Characterization of Photo-Curable Bis-Quaternary Ammonium Dimethacrylate with Antimicrobial Activity for Dental Restoration Materials</article-title>. <source>Eur. Polym. J.</source> <volume>74</volume>, <fpage>81</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2015.11.011</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mankovskaia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>L&#xe9;vesque</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Prakki</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Catechin-incorporated Dental Copolymers Inhibit Growth of Streptococcus Mutans</article-title>. <source>J.&#x20;Appl. Oral Sci.</source> <volume>21</volume>, <fpage>203</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1590/1678-7757201302430</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Busscher</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>van der Mei</surname>
<given-names>H. C.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Influence of Surface Roughness on Streptococcal Adhesion Forces to Composite Resins</article-title>. <source>Dent. Mater.</source> <volume>27</volume>, <fpage>770</fpage>&#x2013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2011.03.017</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namba</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagaoka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Takashima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsuura-Yoshimoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Antibacterial Effect of Bactericide Immobilized in Resin Matrix</article-title>. <source>Dent. Mater.</source> <volume>25</volume>, <fpage>424</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2008.08.012</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neto</surname>
<given-names>E. M. R.</given-names>
</name>
<name>
<surname>Valadas</surname>
<given-names>L. A. R.</given-names>
</name>
<name>
<surname>Lobo</surname>
<given-names>P. L. D.</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>A. M. B.</given-names>
</name>
<name>
<surname>da Cruz Fonseca</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Fechine</surname>
<given-names>F. V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Dose-response Evaluation of Propolis Dental Varnish in Children: A Randomized Control Study</article-title>. <source>Recent Pat. Biotechnol.</source> <volume>14</volume>, <fpage>41</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.2174/1872208313666190826145453</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nocca</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ragno</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Martorana</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Rossetti</surname>
<given-names>D. V.</given-names>
</name>
<name>
<surname>Gambarini</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Identification of Glutathione-Methacrylates Adducts in Gingival Fibroblasts and Erythrocytes by HPLC-MS and Capillary Electrophoresis</article-title>. <source>Dent. Mater.</source> <volume>27</volume>, <fpage>e87</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2011.01.002</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oldoni</surname>
<given-names>T. L. C.</given-names>
</name>
<name>
<surname>Cabral</surname>
<given-names>I. S. R.</given-names>
</name>
<name>
<surname>d&#x2019;Arce</surname>
<given-names>M. A. B. R.</given-names>
</name>
<name>
<surname>Rosalen</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Ikegaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nascimento</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Isolation and Analysis of Bioactive Isoflavonoids and Chalcone from a New Type of Brazilian Propolis</article-title>. <source>Separat. Purif. Tech.</source> <volume>77</volume>, <fpage>208</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/j.seppur.2010.12.007</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveirad</surname>
<given-names>J.&#x20;M. S.</given-names>
</name>
<name>
<surname>Silveira Cavalcanti</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>de Souza</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Celerino de Moraes Porto</surname>
<given-names>I. C.</given-names>
</name>
<name>
<surname>Gomes do Nascimento</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>De Paiva e Silva Zanta</surname>
<given-names>C. L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Uso De Pr&#xf3;polis No Desenvolvimento De Resinas Dent&#xe1;rias: Um Estudo Prospectivo</article-title>. <source>Cp</source> <volume>10</volume>, <fpage>285</fpage>&#x2013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.9771/cp.v10i2.20531</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>M. B. S.</given-names>
</name>
<name>
<surname>Valentim</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>J.&#x20;C.</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>K. S. N.</given-names>
</name>
<name>
<surname>Tanabe</surname>
<given-names>E. L. L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Schinus Terebenthifolius Raddi Extracts: From Sunscreen Activity toward protection of the Placenta to Zika Virus Infection, New Uses for a Well-Known Medicinal Plant</article-title>. <source>Ind. Crops Prod.</source> <volume>152</volume>, <fpage>112503</fpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112503</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oryan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alemzadeh</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Moshiri</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Potential Role of Propolis in Wound Healing: Biological Properties and Therapeutic Activities</article-title>. <source>Biomed. Pharmacother.</source> <volume>98</volume>, <fpage>469</fpage>&#x2013;<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.12.069</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parolia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ramamurthy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Madheswaran</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Davamani</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pichika</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Effect of Propolis Nanoparticles against <italic>Enterococcus faecalis</italic> Biofilm in the Root Canal</article-title>. <source>Molecules</source> <volume>26</volume>, <fpage>715</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26030715</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perduns</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Volk</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schertl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leyhausen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Geurtsen</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>HEMA Modulates the Transcription of Genes Related to Oxidative Defense, Inflammatory Response and Organization of the ECM in Human Oral Cells</article-title>. <source>Dent. Mater.</source> <volume>35</volume>, <fpage>501</fpage>&#x2013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2019.01.011</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peycheva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Apostolova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gardjeva</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peychev</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kokova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Angelov</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Effect of Bulgarian Propolis on the Oral Microflora in Adolescents with Plaque-Induced Gingivitis</article-title>. <source>Revista Brasileira de Farmacognosia</source> <volume>29</volume>, <fpage>271</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjp.2018.11.001</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piccinelli</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Lotti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Campone</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cuesta-Rubio</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Campo Fernandez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rastrelli</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cuban and Brazilian Red Propolis: Botanical Origin and Comparative Analysis by High-Performance Liquid Chromatography-Photodiode Array Detection/electrospray Ionization Tandem Mass Spectrometry</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>59</volume>, <fpage>6484</fpage>&#x2013;<lpage>6491</lpage>. <pub-id pub-id-type="doi">10.1021/jf201280z</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Picolotto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pergher</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>K. G.</given-names>
</name>
<name>
<surname>da Silva Barud</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Roesch-Ely</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Bacterial Cellulose Membrane Associated with Red Propolis as Phytomodulator: Improved Healing Effects in Experimental Models of Diabetes Mellitus</article-title>. <source>Biomed. Pharmacother.</source> <volume>112</volume>, <fpage>108640</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108640</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pongprueksa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>De Munck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duca</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Poels</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Covaci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hoet</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Monomer Elution in Relation to Degree of Conversion for Different Types of Composite</article-title>. <source>J.&#x20;Dent.</source> <volume>43</volume>, <fpage>1448</fpage>&#x2013;<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1016/j.jdent.2015.10.013</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porto</surname>
<given-names>I. C. C. d. M.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>A. B. d. B.</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>I. I. S.</given-names>
</name>
<name>
<surname>de Barros</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>&#xc1;vila</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>M. C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Polyphenols and Brazilian Red Propolis Incorporated into a Total-Etching Adhesive System Help in Maintaining Bonding Durability</article-title>. <source>Heliyon</source> <volume>7</volume>, <fpage>e06237</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2021.e06237</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Regueira</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Tintino</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>A. R. P.</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>M. D. S.</given-names>
</name>
<name>
<surname>Boligon</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Matias</surname>
<given-names>E. F. F.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Seasonal Variation of Brazilian Red Propolis: Antibacterial Activity, Synergistic Effect and Phytochemical Screening</article-title>. <source>Food Chem. Toxicol.</source> <volume>107</volume>, <fpage>572</fpage>&#x2013;<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2017.03.052</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ristivojevi&#x107;</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Trifkovi&#x107;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Andri&#x107;</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Milojkovi&#x107;-Opsenica</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Poplar-type Propolis: Chemical Composition, Botanical Origin and Biological Activity</article-title>. <source>Nat. Prod. Commun.</source> <volume>10</volume>, <fpage>1869</fpage>&#x2013;<lpage>1876</lpage>. <pub-id pub-id-type="doi">10.1177/1934578x1501001117</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rufatto</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Luchtenberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thomassigny</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bouttier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Henriques</surname>
<given-names>J.&#x20;A. P.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Brazilian Red Propolis: Chemical Composition and Antibacterial Activity Determined Using Bioguided fractionationBrazilian Red Propolis: Chemical Composition and Antibacterial Activity Determined Using Bioguided Fractionation</article-title>. <source>Microbiol. Res.Microbiol. Res.</source> <volume>214</volume>, <fpage>774</fpage>&#x2013;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2018.05.003</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xfc;ttermann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Trellenkamp</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Beikler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ritter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Janda</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Bacterial Viability and Physical Properties of Antibacterially Modified Experimental Dental Resin Composites</article-title>. <source>PLoS One</source> <volume>8</volume>, <fpage>e79119</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0079119</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santiago</surname>
<given-names>K. B.</given-names>
</name>
<name>
<surname>Piana</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Conti</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Cardoso</surname>
<given-names>E. O.</given-names>
</name>
<name>
<surname>Murbach Teles Andrade</surname>
<given-names>B. F.</given-names>
</name>
<name>
<surname>Zanutto</surname>
<given-names>M. R.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Microbiological Control and Antibacterial Action of a Propolis-Containing Mouthwash and Control of Dental Plaque in Humans</article-title>. <source>Nat. Prod. Res.</source> <volume>32</volume>, <fpage>1441</fpage>&#x2013;<lpage>1445</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2017.1344664</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schweikl</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Spagnuolo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmalz</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Genetic and Cellular Toxicology of Dental Resin Monomers</article-title>. <source>J.&#x20;Dent. Res.</source> <volume>85</volume>, <fpage>870</fpage>&#x2013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1177/154405910608501001</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sforcin</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Bankova</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Propolis: Is There a Potential for the Development of New Drugs?</article-title> <source>J.&#x20;Ethnopharmacol.</source> <volume>133</volume>, <fpage>253</fpage>&#x2013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2010.10.032</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sies</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Berndt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Oxidative Stress</article-title>. <source>Annu. Rev. Biochem.</source> <volume>86</volume>, <fpage>715</fpage>&#x2013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-biochem-061516-045037</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Macedo</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Trentin</surname>
<given-names>D. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Plant Natural Products Targeting Bacterial Virulence Factors</article-title>. <source>Chem. Rev.</source> <volume>116</volume>, <fpage>9162</fpage>&#x2013;<lpage>9236</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00184</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavassoli Hojati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alaghemand</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hamze</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ahmadian Babaki</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rajab-Nia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rezvani</surname>
<given-names>M. B.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Antibacterial, Physical and Mechanical Properties of Flowable Resin Composites Containing Zinc Oxide Nanoparticles</article-title>. <source>Dent. Mater.</source> <volume>29</volume>, <fpage>495</fpage>&#x2013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2013.03.011</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname>
<given-names>E. W.</given-names>
</name>
<name>
<surname>Negri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Meira</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Message</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Salatino</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Plant Origin of green Propolis: Bee Behavior, Plant Anatomy and Chemistry</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>2</volume>, <fpage>85</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1093/ecam/neh055</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vouvoudi</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Achilias</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Sideridou</surname>
<given-names>I. D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Dental Light-Cured Nanocomposites Based on a Dimethacrylate Matrix: Thermal Degradation and Isoconversional Kinetic Analysis in N2 Atmosphere</article-title>. <source>Thermochim. Acta</source> <volume>599</volume>, <fpage>63</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.tca.2014.11.017</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Larm</surname>
<given-names>N. E.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Incorporation of Antibacterial Agent Derived Deep Eutectic Solvent into an Active Dental Composite</article-title>. <source>Dent. Mater.</source> <volume>33</volume>, <fpage>1445</fpage>&#x2013;<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2017.09.014</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Modification of Membrane Properties and Fatty Acids Biosynthesis-Related Genes in <italic>Escherichia coli</italic> and <italic>Staphylococcus aureus</italic>: Implications for the Antibacterial Mechanism of Naringenin</article-title>. <source>Biochim. Biophys. Acta Biomembr</source> <volume>1860</volume>, <fpage>481</fpage>&#x2013;<lpage>490</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2017.11.007</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiatrak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morawiec</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>R&#xf3;j</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mertas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Machorowska-Pieni&#x105;&#x17c;ek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kownacki</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Oral Health of Patients Treated with Acrylic Partial Dentures Using a Toothpaste Containing Bee Product</article-title>. <source>Evidence-Based Complement. Altern. Med.</source> <volume>2017</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1155/2017/4034179</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woisky</surname>
<given-names>R. G.</given-names>
</name>
<name>
<surname>Salatino</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Analysis of Propolis: Some Parameters and Procedures for Chemical Quality Control</article-title>. <source>J.&#x20;Apicultural Res.</source> <volume>37</volume>, <fpage>99</fpage>&#x2013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1080/00218839.1998.11100961</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antibacterial Activities of Flavonoids: Structure-Activity Relationship and Mechanism</article-title>. <source>Curr. Med. Chem.</source> <volume>22</volume>, <fpage>132</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.2174/0929867321666140916113443</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Reichl</surname>
<given-names>F. X.</given-names>
</name>
<name>
<surname>Ilie</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dhein</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hickel</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Antioxidants as a Novel Dental Resin-Composite Component: Effect on Elution and Degree of Conversion</article-title>. <source>Dent. Mater.</source> <volume>35</volume>, <fpage>650</fpage>&#x2013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1016/j.dental.2019.02.003</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chai</surname>
<given-names>Z. G.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Antifungal Effects and Mechanical Properties of Silver Bromide/cationic Polymer Nano-Composite-Modified Poly-Methyl Methacrylate-Based Dental Resin</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>1547</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-01686-4</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zulhendri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Felitti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fearnley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ravalia</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Use of Propolis in Dentistry, Oral Health, and Medicine: A Review</article-title>. <source>J.&#x20;Oral Biosci.</source> <volume>63</volume>, <fpage>23</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.job.2021.01.001</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>